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Abstract	  	  	   Epithelial	  cells	  lining	  the	  upper	  airways	  are	  characterized	  by	  low	  sodium	  absorption	  and	  elevated	  chloride	  secretion.	  Together,	  the	  movement	  of	  these	  ions	  creates	  the	  osmotic	  drive	  to	  hydrate	  the	  airways.	  Recent	  studies	  indicate	  that	  influenza	  is	  capable	  of	  directly	  modulating	  the	  vectorial	  transport	  of	  sodium	  and	  chloride	  ions.	  However,	  the	  direct	  impact	  of	  influenza	  has	  not	  been	  studied	  with	  respect	  to	  potassium	  channels.	  This	  is	  significant	  because	  potassium	  conductance	  creates	  the	  driving	  force	  for	  chloride	  secretion.	  Disruptions	  to	  this	  process	  leads	  to	  edema	  formation	  in	  the	  lungs	  and	  can	  subsequently	  cause	  Acute	  Respiratory	  Distress	  Syndrome.	  Additionally,	  it	  has	  been	  demonstrated	  that	  the	  induction	  of	  pro-­‐inflammatory	  cytokines	  in	  infected	  cells	  may	  contribute	  to	  altered	  ion	  channel	  function,	  further	  exacerbating	  edema	  formation.	  The	  purpose	  of	  this	  study	  was	  to	  assess	  the	  direct	  and	  indirect	  effects	  of	  influenza	  virus	  infection	  on	  potassium	  and	  chloride	  ion	  channel	  function	  in	  a	  secretory	  epithelial	  cell	  model.	  	  	   In	  order	  to	  assess	  the	  direct	  effects	  we	  exposed	  polarized	  epithelial	  cell	  monolayers	  to	  varying	  doses	  of	  H1N1	  virus.	  Potassium	  and	  chloride	  channel	  function	  was	  measured	  by	  means	  of	  short-­‐circuit	  current	  in	  an	  Ussing	  chamber.	  The	  immune	  response	  to	  viral	  infection	  was	  determined	  by	  RT-­‐qPCR	  and	  Bioplex	  suspension	  array.	  Virus	  conditioned	  media	  (CM),	  and	  IL-­‐8	  were	  used	  to	  characterize	  the	  indirect	  effects	  on	  non-­‐infected	  cells.	  	  	   We	  observed	  an	  increase	  in	  chloride	  secretion,	  consistent	  with	  edema	  formation,	  when	  60%	  of	  the	  epithelium	  was	  infected,	  and	  after	  CM	  treatment.	  This	  observation	  correlated	  with	  increased	  potassium	  channel	  conductance	  through	  the	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calcium-­‐activated	  (KCNN4)	  and	  cAMP-­‐activated	  potassium	  channels	  (KCNQ1),	  which	  was	  ameliorated	  upon	  specific	  inhibition	  of	  these	  channels.	  The	  data	  suggest	  that	  the	  mixture	  of	  pro-­‐inflammatory	  cytokines	  induced	  by	  viral	  infection	  directly	  up-­‐regulate	  these	  potassium	  channels.	  However,	  treatment	  with	  IL-­‐8	  also	  appears	  to	  increase	  chloride	  secretion,	  although	  the	  underlying	  mechanism	  remains	  to	  be	  determined,	  as	  it	  is	  not	  mediated	  through	  KCNN4	  and	  KCNQ1.	  We	  conclude	  that	  the	  strong	  induction	  of	  cytokines	  in	  infected	  cells	  act	  in	  a	  paracrine	  manner	  on	  non-­‐infected	  cells	  to	  increase	  potassium	  channel	  conductance.	  This	  up-­‐regulation	  of	  potassium	  channels	  subsequently	  drives	  an	  increase	  in	  chloride	  secretion,	  leading	  to	  fluid	  build-­‐up	  in	  the	  lungs	  and	  edema	  formation.	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CHAPTER	  1.	  LITERATURE	  REVIEW	  
1.1.	  Background	  
1.1.1.	  Influenza	  A	  virus	  	   Influenza	  A	  virus	  is	  part	  of	  the	  Orthomyxoviridae	  family	  of	  negative-­‐stranded	  RNA	  viruses[1].	  The	  viral	  genome	  is	  comprised	  of	  eight	  segments,	  which	  code	  for	  11	  different	  proteins[2].	  Two	  of	  these	  proteins,	  hemagglutinin	  (HA)	  and	  neuraminidase	  (NA),	  are	  found	  on	  the	  viral	  envelope;	  differences	  among	  these	  proteins	  allow	  for	  classification	  of	  influenza	  subtypes	  (e.g.,	  H1N1,	  H5N1,	  etc)[3].	  H1N1,	  in	  particular,	  has	  been	  widely	  studied,	  as	  it	  has	  been	  the	  cause	  of	  at	  least	  two	  worldwide	  pandemics	  since	  the	  early	  1900’s[1].	  Influenza	  A	  viruses	  can	  infect,	  and	  transmit	  between,	  a	  wide	  variety	  of	  hosts;	  human,	  swine	  and	  avian	  hosts	  are	  most	  common[3,4].	  	  In	  nature,	  multiple	  strains	  of	  influenza	  virus	  can	  infect	  the	  same	  host[5].	  When	  this	  occurs,	  the	  genomes	  of	  the	  different	  viruses	  can	  mix,	  causing	  dramatic	  changes	  to	  the	  surface	  glycoproteins[1,5,6].	  This	  leads	  to	  the	  formation	  of	  pandemic	  strains	  and	  is	  defined	  as	  antigenic	  shift[2,7].	  Alternatively,	  seasonal	  strains	  of	  influenza	  arise	  from	  a	  process	  termed	  antigenic	  drift,	  which	  refers	  to	  minor	  changes	  in	  the	  surface	  glycoproteins	  that	  arise	  due	  to	  mutation[6,7].	  Efforts	  to	  protect	  individuals	  against	  influenza	  infection	  have	  been	  largely	  unsuccessful	  in	  the	  long	  term	  because	  of	  the	  ability	  of	  the	  virus	  to	  undergo	  both	  antigenic	  drift	  and	  antigenic	  shift[5].	  Since	  these	  processes	  occur	  randomly,	  and	  the	  mutation	  rate	  is	  also	  influenced	  by	  the	  host	  immune	  system,	  it	  is	  difficult	  to	  consistently	  predict	  the	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annual	  circulating	  strains[8,9].	  This	  poses	  a	  significant	  challenge	  to	  researchers	  in	  the	  development	  of	  vaccines[8].	  Therefore,	  for	  effective	  management	  of	  infected	  patients	  an	  understanding	  of	  the	  pulmonary	  pathophysiology	  associated	  with	  influenza	  infection	  is	  required.	  	  
1.1.2.	  Overview	  of	  airway	  epithelium	  	   The	  entire	  respiratory	  tract	  is	  lined	  with	  epithelial	  cells,	  which	  provide	  a	  physical	  barrier	  to	  inhaled	  environmental	  pathogens[10,11].	  The	  epithelial	  cells	  form	  tight	  junctions,	  dividing	  the	  cells	  into	  apical	  (airway-­‐facing)	  and	  basolateral	  (blood-­‐facing)	  surfaces[10].	  	  In	  general,	  ion	  channels	  localized	  to	  either	  the	  apical	  or	  basolateral	  surface	  of	  these	  cells	  work	  in	  concert	  to	  move	  solutes,	  creating	  the	  osmotic	  drive	  to	  move	  water	  into	  or	  out	  of	  the	  airways[11].	  This	  entire	  process	  is	  driven	  by	  the	  basolaterally	  located	  3Na+/2K+-­‐ATPase	  pump,	  which	  pumps	  out	  three	  sodium	  ions	  (Na+)	  in	  exchange	  for	  two	  potassium	  ions	  (K+)[11].	  This	  creates	  the	  electrochemical	  gradient	  that	  drives	  the	  passive	  “leakage”	  of	  sodium,	  chloride,	  and	  potassium	  through	  ion	  channels[11,12].	  Maintenance	  of	  a	  healthy	  lung	  is	  dependent	  on	  these	  ion	  transport	  processes,	  as	  they	  generate	  the	  osmotic	  drive	  to	  hydrate	  the	  airways[12].	  This	  pump-­‐leak	  model	  of	  ion	  transport	  regulates	  the	  fluid	  volume	  in	  the	  lung,	  maintaining	  it	  at	  appropriate	  levels	  to	  ultimately	  facilitate	  proper	  gas	  exchange[11,13].	  This	  model	  outlines	  the	  basic	  driving	  force	  for	  the	  movement	  of	  solutes	  and	  water	  in	  the	  airways.	  However,	  ion	  channel	  distribution	  differs	  between	  cell	  types,	  changing	  the	  cellular	  or	  tissue	  phenotype.	  Cell	  type	  distribution	  varies	  between	  the	  upper	  and	  lower	  respiratory	  tract	  (detailed	  below);	  it	  is	  this	  variation	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that	  partially	  determines	  the	  secretory	  or	  absorptive	  characteristics	  of	  the	  upper	  and	  lower	  airways,	  respectively[14].	  
1.1.1.1.	  Upper	  respiratory	  tract	  
	   The	  upper	  respiratory	  tract	  is	  comprised	  of	  the	  nasal	  cavity,	  and	  trachea[11].	  Epithelial	  cells	  lining	  the	  upper	  airways	  form	  the	  surface	  epithelium,	  which	  contains	  a	  number	  of	  different	  cell	  types	  that	  contribute	  to	  airway	  hydration[11].	  In	  addition,	  submucosal	  glands	  underlying	  the	  surface	  epithelium	  contribute	  to	  fluid	  secretion[14,15,16].	  The	  majority	  of	  the	  fluid	  is	  secreted	  by	  serous	  cells,	  which	  predominate	  the	  acinus	  (base)	  of	  the	  submucosal	  glands[14,15].	  Movement	  of	  fluid	  through	  the	  glands	  subsequently	  pushes	  out	  mucus	  generated	  by	  mucus	  cells	  located	  further	  up	  the	  duct[14,17].	  This	  fluid,	  now	  termed	  periciliary	  fluid,	  supports	  the	  mucus	  layer	  and	  together	  these	  form	  the	  airway	  surface	  liquid	  (ASL)[11,15].	  The	  ASL	  is	  maintained	  through	  both	  anion	  and	  cation	  transport	  processes	  across	  the	  epithelium,	  which	  is	  essential	  for	  mucociliary	  clearance[11,12,18].	  	  	   The	  ciliary	  beat,	  which	  facilitates	  mucociliary	  clearance,	  is	  dependent	  on	  appropriate	  periciliary	  fluid	  volume,	  which	  elevates	  the	  mucus	  above	  the	  cilia[14,18].	  The	  mucus	  layer	  traps	  debris	  and	  is	  subsequently	  removed	  from	  the	  airways[19].	  Hydration	  of	  the	  mucus	  also	  reduces	  the	  viscosity,	  facilitating	  mucociliary	  clearance[20].	  Overall,	  this	  process	  is	  a	  large	  part	  of	  the	  innate	  immune	  system	  in	  the	  lungs[18,19].	  	  	   The	  ion	  transport	  processes	  that	  drive	  ASL	  formation	  are	  outlined	  in	  Figure	  1.	  The	  electrochemical	  gradient	  that	  drives	  fluid	  secretion	  is	  maintained	  through	  the	  active	  pumping	  action	  of	  the	  basolateral	  Na+/K+-­‐ATPase,	  which	  exchanges	  3Na+	  for	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2K+[12].	  The	  stoichiometry	  creates	  a	  charge	  separation	  resulting	  in	  a	  high	  internal	  potassium	  concentration	  and	  low	  internal	  Na+[21].	  Naturally,	  Na+	  follows	  its	  electrochemical	  gradient	  and	  moves	  into	  the	  cell	  via	  the	  apical	  epithelial	  sodium	  channel	  (ENaC)[12,22].	  The	  efflux	  of	  K+	  from	  the	  apical	  and/or	  basolateral	  membranes,	  facilitated	  through	  K+	  channels	  (e.g.,	  KCNN4,	  KCNQ1),	  increases	  the	  negative	  change	  within	  the	  cell,	  hyperpolarizing	  the	  membrane,	  and	  driving	  chloride	  (Cl-­‐)	  secretion[11,12,23].	  In	  the	  apical	  membrane,	  Cl-­‐	  moves	  through	  two	  different	  channels:	  the	  cAMP-­‐activated	  cystic	  fibrosis	  transmembrane	  regulator	  (CFTR)	  channel,	  and	  the	  calcium-­‐activated	  chloride	  channel	  (CaCC)[11].	  TMEM16A	  is	  the	  primary	  CaCC	  present	  in	  airway	  epithelium;	  however,	  this	  channel	  accounts	  for	  a	  smaller	  proportion	  of	  the	  overall	  chloride	  conductance	  in	  comparison	  to	  CFTR[24,25].	  The	  intracellular	  stores	  of	  Cl-­‐	  are	  replenished	  by	  the	  electroneutral	  intake	  of	  Na+,	  K+,	  and	  2Cl-­‐	  on	  the	  basolateral	  side	  via	  NKCC1[11].	  In	  the	  upper	  airways,	  CFTR	  is	  highly	  abundant	  and	  acts	  to	  down-­‐regulate	  ENaC	  function,	  leading	  to	  reduced	  Na+	  absorption	  across	  the	  apical	  membrane[26,27].	  This	  combined	  effect	  of	  Na+	  and	  Cl-­‐	  transport	  generates	  a	  strong	  osmotic	  drive	  for	  hydrating	  the	  upper	  airways.	  Water	  then	  follows	  this	  osmotic	  gradient,	  moving	  either	  paracellularly,	  or	  through	  apical	  and	  basolateral	  aquaporin	  channels	  (AQP5,	  3,	  4),	  hydrating	  the	  airways[20,28].	  
1.1.1.2.	  Lower	  respiratory	  tract	  	   The	  lower	  respiratory	  tract	  is	  made	  up	  of	  the	  bronchi	  and	  alveoli[11].	  The	  bronchi	  are	  covered	  by	  surface	  epithelium,	  and	  is	  aglandular[15].	  The	  alveolar	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Figure	  1.	  Overview	  of	  upper	  respiratory	  tract	  ion	  transport	  processes.	  	  	  	  Represented	  are	  the	  Na+,	  Cl-­‐,	  and	  K+	  channels,	  along	  with	  their	  respective	  transporters.	  This	  diagram	  represents	  the	  channels	  in	  different	  cells	  for	  simplicity.	  The	  apical	  side	  corresponds	  to	  the	  airspace,	  where	  the	  ASL	  is	  secreted.	  Submucosal	  gland	  serous	  cell	  secretions	  create	  the	  osmotic	  drive	  to	  generate	  the	  ASL	  (see	  text	  for	  details).	  Upper	  respiratory	  cells	  are	  characteristically	  secretory	  in	  order	  to	  maintain	  appropriate	  ASL	  volumes	  to	  facilitate	  mucociliary	  clearance.	  ENaC	  =	  epithelial	  sodium	  channel,	  comprised	  of	  three	  subunits	  (α,	  β,	  and	  γ).	  CFTR	  =	  cystic	  fibrosis	  transmembrane	  regulator	  channel.	  CaCC	  =	  calcium-­‐activated	  chloride	  channel	  (TMEM16A).	  AQP	  =	  aquaporin	  (H2O)	  channels.	  KCNN4	  =	  calcium-­‐activated	  potassium	  channel.	  *	  =	  Apical	  potassium	  channel;	  varies	  between	  cell	  type.	  NKCC	  =	  Na+/K+/2Cl-­‐	  co-­‐transporter.	  ATPase	  =	  Na+/K+-­‐ATPase.	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epithelium	  is	  made	  up	  of	  two	  different	  cell	  types,	  alveolar	  type	  I	  (ATI)	  and	  type	  II	  (ATII)	  cells.	  ATI	  cells	  are	  large	  and	  squamous,	  comprising	  over	  95%	  of	  the	  epithelial	  surface[29].	  Their	  main	  function	  is	  gas	  exchange;	  however,	  there	  is	  evidence	  supporting	  their	  role	  in	  maintaining	  lung	  fluid	  homeostasis	  through	  both	  ion	  and	  water	  transport	  (Figure	  2)[30,31].	  These	  cells	  are	  extremely	  permeable	  to	  water,	  as	  they	  express	  high	  levels	  of	  aquaporin	  5	  (AQP5)	  in	  their	  apical	  membrane[30,32].	  More	  recent	  evidence	  has	  indicated	  that	  ATI	  cells	  contain	  several	  cation	  channels	  both	  amiloride-­‐sensitive	  (ENaC),	  and	  –insensitive	  channels,	  and	  the	  basolateral	  Na+/K+-­‐ATPase[30,31,33].	  This	  basolateral	  pump	  creates	  the	  electrochemical	  gradient	  for	  the	  apical	  absorption	  of	  Na+[30].	  Apical	  chloride	  (Cl-­‐)	  channels,	  namely	  CFTR,	  facilitate	  the	  movement	  of	  Cl-­‐	  in	  order	  to	  maintain	  electroneutrality[33].	  	  Additionally,	  evidence	  suggests	  that	  both	  ATI	  and	  ATII	  cells	  contain	  potassium	  (K+)	  channels	  in	  the	  apical	  membrane[34].	  The	  outward	  movement	  of	  K+	  further	  drives	  fluid	  absorption	  in	  the	  lower	  airways[30].	  Overall,	  the	  low	  levels	  of	  CFTR	  and	  high	  abundance	  of	  Na+	  channels	  relative	  to	  the	  upper	  airways	  promote	  an	  absorptive	  phenotype[30,32].	  	  	   ATII	  cells	  are	  much	  smaller,	  and	  make	  up	  the	  remaining	  5%	  of	  the	  alveolar	  epithelial	  surface[11].	  They	  secrete	  surfactants,	  which	  are	  important	  for	  reducing	  surface	  tension,	  and	  promoting	  gas	  exchange[11,35].	  Similar	  to	  the	  ATI	  cells,	  the	  basolateral	  membrane	  contains	  a	  Na+/K+-­‐ATPase	  responsible	  for	  driving	  the	  net	  absorption	  of	  fluid,	  making	  the	  driving	  forces	  for	  fluid	  absorption	  in	  ATII	  cells	  nearly	  identical	  to	  those	  in	  ATI	  cells[30,31].	  The	  main	  difference	  observed	  between	  ATI	  and	  ATII	  cells	  is	  the	  lack	  of	  aquaporins	  in	  ATII	  cells	  (Figure	  2)[32,36].	  Despite	  this	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difference,	  the	  net	  movement	  of	  fluid	  in	  the	  lower	  airways	  remains	  apical	  to	  basolateral,	  as	  a	  result	  of	  the	  vectorial	  transport	  of	  Na+	  and	  Cl-­‐.	  This	  creates	  the	  osmotic	  drive	  to	  move	  water	  across	  the	  apical	  membrane.	  	  This	  vectorial	  transport	  in	  the	  lower	  respiratory	  tract	  is	  made	  possible	  by	  the	  presence	  of	  both	  ENaC	  and	  CFTR[22,30,37,38].	  Although	  the	  roles	  for	  both	  of	  these	  ion	  channels	  have	  been	  widely	  studied,	  there	  is	  no	  consensus	  on	  whether	  alveolar	  cells	  generally	  act	  in	  a	  secretory	  or	  absorptive	  manner[11,29,30,36,39].	  Since	  many	  different	  models	  have	  been	  employed	  to	  study	  the	  lower	  airways	  (see	  “Models	  for	  
studying	  chloride	  conductance	  in	  the	  lower	  airway”),	  it	  has	  been	  difficult	  to	  accurately	  determine	  the	  phenotype	  as	  being	  either	  secretory	  or	  absorptive.	  However,	  we	  know	  that	  hydrostatic	  pressure	  forces	  fluid	  into	  the	  airways,	  and	  that	  the	  upper	  airways	  secrete	  fluid	  to	  form	  the	  ASL[39,40].	  Additionally,	  there	  is	  a	  growing	  body	  of	  evidence	  surrounding	  the	  presence	  of	  multiple	  different	  sodium	  channels	  in	  the	  alveolar	  epithelium,	  which	  would	  increase	  the	  absorptive	  capacity[30,32,40].	  Taken	  together,	  it	  would	  seem	  reasonable	  to	  conclude	  that,	  in	  general,	  the	  lower	  respiratory	  tract	  has	  the	  capacity	  and	  the	  need	  to	  absorb	  fluid.	  However,	  there	  is	  evidence	  to	  support	  both	  absorptive	  and	  secretory	  characteristics	  to	  maintain	  lung	  liquid	  homeostasis.	  
1.1.3.	  Epithelial	  immune	  response	  to	  influenza	  virus	  infection	  
	   Influenza	  viruses	  primarily	  attach	  to,	  and	  infect,	  ciliated	  epithelial	  cells	  of	  the	  upper	  respiratory	  tract[7,35].	  The	  viral	  hemagglutinin	  binds	  to	  sialic	  acid	  residues,	  arranged	  either	  in	  the	  α2,6-­‐	  or	  α2,3	  linkage[41].	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Figure	  2.	  Overview	  of	  the	  lower	  respiratory	  tract	  ion	  transport	  processes	  ATI	  and	  ATII	  cells	  play	  a	  role	  in	  vectorial	  ion	  transport	  driven	  through	  the	  Na+/K+-­‐ATPase	  (see	  text	  for	  details).	  ATI	  cells	  are	  responsible	  for	  transporting	  a	  large	  portion	  of	  H2O	  via	  aquaporin	  5	  in	  the	  apical	  membrane.	  The	  presence	  of	  Na+,	  Cl-­‐,	  and	  K+	  channels	  in	  both	  cells	  is	  evidence	  that	  the	  alveolar	  epithelium,	  in	  general,	  is	  responsible	  for	  helping	  maintain	  lung	  liquid	  homeostasis.	  ATI	  =	  alveolar	  type	  I	  cells.	  ATII	  =	  alveolar	  type	  II	  cells.	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The	  affinity	  of	  hemagglutinin	  for	  a	  particular	  form	  of	  sialic	  acid	  is	  highly	  dependent	  on	  the	  species	  that	  the	  virus	  naturally	  infects	  (e.g.,	  human	  virus	  isolates	  tend	  to	  prefer	  the	  α2,6	  linkage)[42,43].	  The	  α2,6	  linkage	  is	  abundant	  in	  the	  upper	  airways,	  making	  this	  the	  primary	  site	  of	  infection	  for	  strains	  such	  as	  H1N1[41].	  However,	  epithelial	  cells	  in	  the	  lower	  airways	  are	  also	  permissive	  to	  influenza	  infection[7,35].	  They	  become	  infected	  as	  a	  result	  of	  increased	  viral	  load[35].	  This	  movement	  of	  the	  virus	  into	  the	  lower	  airways	  results	  in	  complications,	  such	  as	  viral	  pneumonia[35,44].	  ATI	  and	  ATII	  cells	  work	  together	  to	  clear	  excess	  fluid	  from	  the	  airspace	  (see	  above,	  “Lower	  respiratory	  tract”).	  This	  ability	  is	  severely	  compromised	  during	  influenza	  virus	  infection,	  and	  results	  in	  flooding	  of	  fluid	  into	  the	  airspace[44].	  The	  main	  consequence	  is	  poor	  gas	  exchange,	  due	  to	  the	  development	  of	  pulmonary	  edema[7,23].	  This	  edema	  formation	  is	  partly	  driven	  by	  changes	  in	  the	  epithelium	  induced	  by	  both	  the	  virus	  and	  the	  host	  innate	  immune	  response[45].	  This	  immune	  response	  is	  two-­‐fold	  and	  includes	  both	  resident	  alveolar	  macrophages	  present	  in	  the	  lung,	  as	  well	  as	  the	  epithelial	  cells	  themselves[44].	  	  	   Resident	  alveolar	  macrophages	  present	  in	  the	  lung	  are	  the	  first	  immune	  cells	  to	  encounter	  inhaled	  pathogens[46].	  Encountering	  a	  pathogen	  activates	  these	  cells,	  which	  then	  secrete	  various	  cytokines	  and	  chemokines	  in	  order	  to	  stimulate	  the	  innate	  immune	  system.	  The	  most	  common	  pro-­‐inflammatory	  cytokine	  produced	  by	  macrophages	  is	  tumor	  necrosis	  factor-­‐α	  (TNF-­‐α)[46,47].	  TNF-­‐α	  is	  an	  important	  immune	  mediator,	  and	  has	  also	  been	  shown	  to	  impact	  sodium	  ion	  transport	  through	  down-­‐regulation	  of	  ENaC	  (see	  “Role	  of	  pro-­inflammatory	  cytokines”)[48].	  These	  secreted	  products	  drive	  an	  inflammatory	  response	  by	  recruiting	  dendritic	  cells,	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natural	  killer	  cells,	  neutrophils,	  and	  T	  lymphocytes	  to	  the	  site	  of	  infection[46,49].	  	  	   The	  epithelial	  cells	  also	  have	  the	  capacity	  to	  contribute	  to	  the	  inflammatory	  response	  after	  viral	  infection[10,19,50,51].	  Recognition	  of	  pathogen-­‐associated	  molecular	  patterns	  (PAMPs)	  via	  pattern	  recognition	  receptors	  (PRRs)	  such	  as	  toll-­‐like	  receptor	  (TLR)	  3	  and	  TLR7,	  as	  well	  as	  the	  retinoic	  acid	  inducible	  gene-­‐I	  (RIG-­‐I),	  results	  in	  the	  release	  of	  cytokines	  and	  chemokines	  from	  epithelial	  cells	  (see	  “Activation	  of	  the	  innate	  immune	  system”)[10,52,53].	  The	  production	  of	  pro-­‐inflammatory	  cytokines	  (e.g.,	  IL-­‐6,	  IFN-­‐γ,	  IL-­‐8,	  IL-­‐1β,	  etc)	  aids	  in	  promoting	  an	  antiviral	  state,	  and	  further	  recruits	  immune	  cells[54,55].	  However,	  this	  strong	  pro-­‐inflammatory	  cytokine	  response	  elicited	  from	  both	  macrophages	  and	  the	  epithelium	  has	  been	  implicated	  in	  the	  development	  of	  ARDS[46,56].	  This	  syndrome,	  which	  can	  result	  from	  infection,	  or	  any	  traumatic	  injury	  to	  the	  lung,	  is	  driven	  by	  the	  release	  of	  a	  cytokine	  cascade[57].	  The	  inflammatory	  response	  associated	  with	  ARDS	  likely	  contributes	  to	  the	  formation	  of	  pulmonary	  edema	  by	  disrupting	  the	  vectorial	  ion	  transport.	  More	  specifically,	  it	  is	  likely	  the	  cytokines,	  which	  have	  been	  shown	  to	  modify	  ion	  transport,	  that	  drive	  this	  pulmonary	  edema	  formation	  (see	  “Role	  of	  pro-­
inflammatory	  cytokines”)[48,58,59].	  	   	  	   The	  strong	  inflammatory	  cytokine	  release	  responsible	  for	  ARDS,	  and	  the	  resulting	  pulmonary	  edema,	  has	  not	  been	  properly	  investigated	  in	  a	  secretory	  model.	  Currently,	  studies	  looking	  at	  the	  direct	  effect	  of	  influenza	  infection	  on	  a	  secretory	  model	  are	  very	  limited,	  as	  most	  studies	  have	  been	  focused	  on	  the	  inhibition	  of	  absorption[60,61,62].	  It	  is	  for	  these	  reasons	  we	  chose	  a	  secretory	  cell	  model,	  Calu3,	  to	  study	  the	  effects	  of	  the	  virus,	  as	  well	  as	  the	  immune	  response	  on	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fluid	  secretion.	  The	  Calu3	  cell	  line	  is	  derived	  from	  a	  human	  lung	  adenocarcinoma,	  and	  has	  been	  well	  characterized	  in	  the	  literature	  as	  a	  useful	  model	  for	  studying	  submucosal	  gland	  serous	  cells[63,64,65].	  These	  cells	  have	  been	  shown	  to	  be	  permissive	  to	  both	  human	  and	  avian	  strains	  of	  influenza,	  making	  it	  an	  excellent	  model	  to	  study	  the	  effects	  of	  the	  virus[4,66,67].	  Additionally,	  Calu3	  cells	  form	  polarized	  monolayers	  with	  tight	  junctions	  in	  culture;	  these	  monolayers	  allow	  for	  the	  study	  of	  transepithelial	  ion	  transport,	  as	  measured	  by	  short-­‐circuit	  current	  in	  an	  Ussing	  chamber[63,68].	  They	  also	  express	  high	  levels	  of	  CFTR,	  and	  have	  been	  shown	  to	  contain	  basolateral	  potassium	  channels[64,65].	  These	  potassium	  channels	  play	  a	  key	  role	  in	  driving	  apical	  anion	  secretion[65,69].	  This	  immortal	  cell	  line	  provides	  a	  dependable,	  convenient	  and	  reproducible	  model	  for	  studying	  the	  interactions	  between	  virus	  and	  host	  with	  respect	  to	  ion	  transport,	  and	  cytokine	  response[66].	  	  	  
1.2.	  Direct	  effects	  of	  influenza	  on	  epithelial	  cell	  ion	  channel	  physiology	  
1.2.1.	  Sodium	  absorption	  	   The	  mechanisms	  driving	  Na+	  absorption	  across	  the	  apical	  membrane	  have	  been	  extensively	  studied[27,70,71,72].	  A	  study	  done	  by	  Hummler	  et	  al.,	  identified	  that	  the	  α-­‐subunit	  of	  the	  ENaC	  is	  critical	  immediately	  after	  birth	  in	  clearing	  fluid	  from	  the	  lungs[72].	  The	  inability	  to	  facilitate	  the	  removal	  of	  fluid	  from	  the	  lungs	  of	  
αENaC-­‐deficient	  mice	  resulted	  in	  death,	  due	  to	  respiratory	  failure[72].	  These	  data	  would	  imply	  that	  the	  α-­‐subunit	  plays	  a	  pivotal	  role	  in	  airway	  epithelial	  Na+	  absorption,	  especially	  in	  the	  infant	  lung.	  However,	  in	  the	  adult	  lung,	  a	  balance	  between	  both	  absorptive	  and	  secretory	  processes	  is	  required	  in	  order	  to	  maintain	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ASL	  levels[62,70].	  Disruptions	  to	  the	  fluid	  balance,	  such	  as	  during	  influenza	  infection,	  lead	  to	  a	  reduced	  ability	  to	  clear	  fluid	  from	  the	  lungs.	  	  	   Influenza	  virus	  has	  been	  shown	  in	  the	  initial	  stages	  of	  infection	  to	  inhibit	  sodium	  absorption	  through	  modulation	  of	  ENaC[60,62].	  Kunzelmann	  et	  al.	  exposed	  epithelial	  cells	  to	  UV-­‐inactivated	  influenza	  virus	  (A/PR/8/34	  H1N1)	  for	  1	  hour	  and	  showed	  no	  effect	  on	  the	  amiloride-­‐sensitive	  short-­‐circuit	  current,	  indicating	  that	  the	  inactive	  viral	  proteins	  do	  not	  lead	  to	  any	  downstream	  impacts	  on	  Na+	  absorption	  through	  ENaC[60].	  This	  phenomenon	  contradicts	  their	  conclusions	  from	  subsequent	  experiments	  that	  indicate	  detergent-­‐disrupted	  virus	  was	  able	  to	  inhibit	  Na+	  absorption[60].	  Overall,	  their	  final	  conclusion	  is	  that	  hemagglutinin	  binding	  to	  its	  cellular	  receptor	  leads	  to	  a	  decrease	  in	  Na+	  reabsorption,	  and	  thus	  reduced	  fluid	  clearance	  from	  the	  lungs[60].	  In	  addition	  to	  this,	  Chen	  et	  al.	  showed	  that	  influenza	  A	  virus	  infection	  reduces	  ENaC	  function	  via	  phospholipase	  C-­‐induced	  activation	  of	  PKC.	  This	  occurred	  after	  binding	  of	  hemagglutinin	  to	  the	  cell	  surface	  (Figure	  3)[62].	  Moreover,	  their	  work	  distinguishes	  that	  the	  observed	  reduction	  in	  fluid	  clearance	  is	  a	  result	  of	  decreased	  Na+	  channels,	  and	  not	  a	  result	  of	  increased	  epithelium	  permeability[62].	  This	  distinction	  is	  important	  because	  it	  aids	  in	  the	  understanding	  that	  respiratory	  viruses,	  such	  as	  influenza,	  have	  physiological	  impacts	  that	  supersede	  the	  cytopathic	  effects	  that	  can	  eventually	  compromise	  the	  epithelial	  barrier	  resulting	  in	  increased	  fluid	  permeability.	  Studies	  done	  in	  vivo	  by	  Wolk	  et	  al.,	  provide	  corroborating	  evidence	  to	  support	  the	  role	  that	  PKC	  plays	  in	  ENaC	  down-­‐regulation,	  and	  subsequent	  reduction	  in	  sodium	  reabsorption[61].	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Figure	  3.	  Effects	  of	  activated	  protein	  kinase	  C	  (PKC)	  on	  epithelial	  sodium	  
channel	  (ENaC)	  expression.	  The	  initial	  stages	  of	  influenza	  virus	  infection	  involve	  binding	  of	  the	  hemagglutinin	  to	  sialic	  acid	  residues	  on	  the	  host	  cell.	  Down	  regulation	  of	  ENaC	  has	  been	  detected	  as	  early	  as	  1	  hour	  post-­‐infection	  with	  influenza.	  Binding	  of	  hemagglutinin	  stimulates	  the	  phosphorylation	  of	  phospholipase	  C	  (PLC).	  Once	  phosphorylated,	  PLC	  cleaves	  the	  precursor	  phopholipid	  phosphatidylinositol	  4,5	  biphosphate	  (4,5	  PIP2)	  into	  diacyl	  glycerol	  (DAG)	  and	  inositol	  1,4,5-­‐triphosphate	  (IP3).	  IP3	  binds	  to	  downstream	  receptors	  to	  release	  intracellular	  stores	  of	  calcium	  (Ca2+).	  The	  release	  of	  Ca2+,	  along	  with	  DAG	  work	  together	  to	  activate	  PKC.	  Reactive	  oxygen	  species	  (ROS)	  have	  also	  been	  implicated	  in	  activating	  PKC.	  Activated	  PKC	  acts	  to	  inhibit	  ENaC	  through	  an	  unknown	  mechanism.	  This	  inhibition	  results	  in	  decreased	  Na+	  reabsorption	  across	  the	  apical	  membrane.	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1.2.1.1.	  Involvement	  of	  protein	  kinase	  C	  	   Much	  emphasis	  has	  been	  placed	  on	  the	  regulation	  of	  ENaC	  through	  protein	  kinase	  C	  (PKC)[60,62,70,73,74].	  PKC	  has	  been	  shown	  to	  inhibit	  ENaC	  in	  the	  airways,	  specifically	  targeting	  the	  α-­‐subunit[62,74,75].	  In	  addition,	  PKC	  has	  also	  been	  shown	  to	  inhibit	  ENaC	  in	  renal	  tissue	  through	  inhibition	  of	  the	  β-­‐	  and	  γ-­‐subunits[27,76].	  In	  the	  kidneys,	  these	  subunits	  play	  a	  larger	  role	  in	  ion	  transport	  than	  the	  α-­‐subunit[27].	  Clearly,	  PKC	  activation	  has	  varied	  effects	  on	  ENaC	  in	  different	  tissues[74].	  Furthermore,	  it	  appears	  that	  influenza	  virus	  replication	  is	  actually	  enhanced	  in	  cells	  that	  are	  treated	  with	  sodium	  channel	  inhibitors,	  or	  activators	  of	  PKC[77].	  In	  contrast,	  inhibiting	  PKC	  and/or	  stimulating	  sodium	  channels	  in	  vitro	  reduces	  influenza’s	  ability	  to	  enter	  cells	  and	  replicate[77,78].	  Hoffmann	  et	  al.	  screened	  for	  compounds	  that	  may	  impact	  influenza	  virus	  growth,	  and	  identified	  that	  the	  virus	  is	  sensitive	  to	  fluctuations	  in	  intracellular	  ion	  concentrations;	  therefore,	  the	  down-­‐regulation	  of	  ENaC	  may	  act	  to	  facilitate	  viral	  growth	  and	  proliferation[75].	  Given	  this,	  it	  would	  seem	  reasonable	  to	  assume	  that,	  over	  time,	  the	  virus	  has	  evolved	  this	  strategy	  to	  modulate	  ENaC	  in	  order	  to	  ensure	  its	  success	  in	  replicating.	  Further	  investigation	  using	  the	  viral	  protein,	  M2,	  has	  shown	  that	  there	  is	  an	  increase	  in	  reactive	  species	  (oxygen	  and	  nitrogen),	  which	  act	  to	  down-­‐regulate	  ENaC	  levels	  through	  activation	  of	  PKC[76].	  Although	  the	  exact	  mechanism	  of	  how	  PKC	  acts	  to	  down-­‐regulate	  ENaC	  activity	  is	  not	  fully	  understood,	  there	  are	  a	  number	  of	  competing	  hypotheses[76].	  	   It	  is	  known	  that	  ENaC	  contains	  certain	  domains	  responsible	  for	  binding	  regulatory	  proteins[79].	  One	  of	  these	  proteins,	  Nedd4	  (neuroneal	  precursor	  cells	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expressed	  developmentally	  down-­‐regulated	  4),	  is	  an	  ubiquitin	  protein	  that	  has	  been	  shown	  to	  have	  regulatory	  effects	  on	  ENaC[79,80].	  Elevation	  of	  Nedd4	  protein	  is	  controlled	  by	  release	  of	  intracellular	  Ca2+	  stores,	  and	  this	  increase	  will	  lead	  to	  ubiquitination	  and	  subsequent	  degradation	  of	  ENaC	  (Figure	  4)[79].	  Alternatively,	  as	  proposed	  by	  Wolk	  et	  al.,	  stimulation	  of	  purinergic	  receptor,	  P2Y,	  by	  UTP	  will	  act	  to	  decrease	  Na+	  absorption	  by	  decreasing	  ENaC	  activity[61].	  However,	  this	  pathway	  also	  appears	  to	  require	  the	  activation	  of	  PKC[76,81].	  Taken	  together,	  these	  studies	  display	  a	  role	  PKC	  activation	  plays	  in	  modulating	  ENaC	  levels	  in	  epithelial	  cells.	  More	  specifically,	  PKC	  is	  connected	  to	  the	  modulation	  of	  Na+	  transport	  resulting	  in	  a	  reduced	  ability	  to	  clear	  fluid	  from	  the	  lungs.	  	  	   Interestingly,	  Palmer-­‐Densmore	  et	  al.	  indicated	  that	  stimulation	  of	  epithelial	  cells	  with	  UTP	  increased	  Cl-­‐	  secretion,	  which	  may	  be	  through	  CaCC	  since	  UTP	  causes	  an	  increase	  in	  intracellular	  calcium[81].	  In	  addition,	  PKC	  is	  capable	  of	  activating	  chloride	  channels	  (CFTR),	  which	  also	  has	  implications	  in	  the	  pathogenesis	  of	  influenza	  virus	  infections.	  This	  reciprocal	  activation	  of	  chloride	  secretion	  and	  decreased	  sodium	  absorption	  via	  calcium/PKC	  pathways	  ultimately	  results	  in	  fluid	  secretion	  into	  the	  lungs.	  
	  1.2.2.	  Chloride	  conductance	  	   The	  role	  that	  Cl-­‐	  conductance	  plays	  in	  response	  to	  influenza	  virus	  infection	  is	  less	  well	  defined	  than	  the	  role	  of	  Na+.	  It	  is	  known	  that	  both	  CFTR	  and	  CaCCs	  (TMEM16A)	  play	  an	  important	  role	  in	  driving	  apical	  Cl-­‐	  secretion	  in	  the	  upper	  respiratory	  tract[24,25,82].	  	  This	  process,	  in	  concert	  with	  Na+	  absorption,	  generates	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Figure	  4.	  Overview	  of	  ENaC	  degradation	  pathway	  by	  Nedd4.	  
Schematic	  diagram	  of	  how	  ENaC	  is	  targeted	  for	  degradation	  by	  Nedd4	  (neuroneal	  precursor	  cells	  expressed	  developmentally	  down-­‐regulated	  4).	  1)	  Intracellular	  calcium	  stores	  are	  released.	  This	  is	  mediated	  by	  influenza	  binding	  sialic	  acid	  and	  subsequently	  phosphorylates	  PLC.	  PLC	  activation	  results	  in	  the	  internal	  release	  of	  calcium	  through	  IP3	  (see	  Figure	  5A).	  This	  leads	  to	  increased	  levels	  of	  Nedd4.	  2)	  Nedd4,	  an	  ubiquitin	  protein,	  is	  found	  in	  the	  cytosol.	  It	  is	  translocated	  to	  the	  apical	  membrane.	  3)	  Binding	  domains	  found	  on	  ENaC	  bind	  Nedd4,	  which	  leads	  to	  ubiquitination	  (Ub)	  of	  the	  ENaC	  subunits.	  4)	  This	  ubiquitination	  leads	  to	  endocytosis	  and	  subsequent	  degradation	  of	  ENaC.	  5)	  A	  reduction	  in	  the	  number	  of	  ENaCs	  results	  in	  a	  reduced	  ability	  to	  absorb	  Na+	  across	  the	  apical	  membrane.	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the	  transepithelial	  osmotic	  gradient	  that	  drives	  water	  across	  the	  epithelial	  barrier	  (see	  “Overview	  of	  airway	  epithelium”	  above).	  	  
	   In	  vitro	  models,	  such	  as	  Calu3	  and	  normal	  human	  bronchial	  epithelial	  cells	  (NHBE),	  have	  been	  used	  to	  study	  chloride	  conductance	  in	  the	  upper	  airways[63,64].	  Calu3	  cells,	  in	  particular,	  are	  often	  chosen	  over	  NHBE	  cells,	  as	  they	  are	  well	  characterized	  as	  an	  anion	  secretion	  model[63,67].	  Additionally,	  NHBE	  cells	  are	  a	  primary	  cell	  line	  that	  is	  more	  difficult	  to	  culture	  (relative	  to	  Calu3),	  and	  depending	  on	  culture	  conditions	  they	  may	  express	  different	  cellular	  phenotypes[67,83,84].	  In	  the	  lower	  respiratory	  tract,	  the	  movement	  of	  chloride	  either	  into	  or	  out	  of	  the	  cell	  will	  play	  a	  large	  role	  in	  determining	  whether	  the	  epithelium	  is	  absorptive	  or	  secretory[11,22,85].	  More	  recent	  evidence	  suggests	  that	  the	  lower	  airways	  are	  more	  absorptive;	  however,	  differences	  exist	  between	  the	  models	  used	  to	  study	  the	  lower	  airways.	  This	  is	  likely	  why	  there	  is	  still	  varying	  interpretation	  over	  the	  exact	  role	  chloride	  plays	  in	  either	  absorptive	  or	  secretory	  capacity	  in	  the	  lower	  airways.	  	  
1.2.2.1.	  Models	  for	  studying	  chloride	  conductance	  in	  the	  upper	  airways	  	   In	  the	  upper	  respiratory	  tract,	  both	  the	  surface	  epithelium	  and	  the	  submucosal	  glands	  act	  to	  secrete	  fluid	  into	  the	  airways	  (see	  “Upper	  respiratory	  tract”	  above).	  The	  Calu3	  cell	  line	  is	  an	  ideal	  model	  for	  studying	  anion	  transport,	  as	  they	  endogenously	  express	  high	  levels	  of	  CFTR	  in	  the	  apical	  membrane[63,86].	  A	  cellular	  model,	  as	  described	  by	  Devor	  et	  al.,	  indicates	  that	  Calu3	  cells	  also	  contain	  a	  basolateral	  Na+-­‐K+-­‐ATPase	  pump	  along	  with	  the	  Na+/K+/2Cl-­‐	  cotransporter	  (NKCC1)[64].	  This	  relatively	  simple	  model	  is	  a	  useful	  tool	  for	  studying	  both	  cAMP-­‐	  and	  calcium-­‐activated	  anion	  transport,	  which	  can	  be	  measured	  by	  changes	  in	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transepithelial	  short-­‐circuit	  current[87,88].	  Secretion	  through	  CFTR	  is	  increased	  by	  stimulation	  with	  cAMP[86,89].	  Additionally,	  there	  are	  both	  cAMP-­‐	  and	  calcium-­‐activated	  potassium	  channels,	  which	  are	  responsible	  for	  establishing	  the	  driving	  force	  for	  apical	  chloride	  secretion	  via	  hyperpolarization	  of	  the	  cell	  (see	  “Potassium	  
conductance”	  below)[65,89].	  	  	   Chloride	  transport	  in	  the	  primary	  NHBE	  cell	  line	  is	  nearly	  identical	  to	  that	  of	  Calu3	  cells[90,91].	  Primary	  cell	  lines,	  such	  as	  NHBE,	  offer	  an	  advantage	  over	  immortal	  cell	  lines	  in	  that	  they	  are	  more	  biochemically	  similar	  to	  the	  original	  tissue[92].	  However,	  they	  are	  more	  challenging	  to	  culture,	  and	  variations	  between	  donors	  cannot	  be	  accounted	  for	  properly[88,92].	  Therefore,	  Calu3	  cells	  remain	  a	  primary	  model	  for	  studying	  anion	  secretion[84].	  	  
1.2.2.2.	  Models	  for	  studying	  chloride	  conductance	  in	  the	  lower	  airways	  	   The	  majority	  of	  studies	  performed	  on	  lower	  respiratory	  epithelial	  cells	  use	  primary	  cell	  culture	  models[84,92,93].	  There	  are,	  of	  course,	  limitations	  to	  any	  in	  
vitro	  study,	  given	  the	  nature	  of	  the	  model.	  However,	  the	  models	  for	  alveolar	  cells	  in	  particular	  have	  a	  great	  amount	  of	  diversity[94].	  More	  specifically,	  work	  done	  by	  Brochiero	  et	  al.	  has	  shown	  that	  alveolar	  type	  II	  cells	  grown	  in	  an	  air-­‐liquid	  interface	  (a	  technique	  used	  to	  polarize	  epithelial	  cells)	  express	  higher	  levels	  of	  CFTR	  compared	  to	  those	  grown	  on	  submerged	  supports[22].	  Moreover,	  the	  methods	  used	  for	  removal	  and	  isolation	  of	  alveolar	  cells	  for	  primary	  culture	  vary,	  leading	  to	  considerable	  differences	  in	  cellular	  morphology[30,95].	  This	  change	  in	  cellular	  phenotype	  is	  exacerbated	  over	  time	  in	  culture,	  as	  shown	  by	  both	  Brochiero	  et	  al.,	  and	  Dobbs	  et	  al.[22,95].	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   More	  recently,	  it	  has	  become	  evident	  that	  ATI	  cells	  do,	  in	  fact,	  play	  a	  role	  in	  ion	  transport	  processes[30,31].	  Given	  that	  ATI	  cells	  dominate	  the	  cellular	  population	  in	  the	  lower	  respiratory	  tract,	  understanding	  their	  contribution	  to	  ion	  transport,	  and	  the	  movement	  of	  fluid,	  is	  crucial.	  However,	  the	  isolation	  techniques	  for	  ATI	  cells	  are	  less	  developed	  than	  those	  for	  ATII	  cells[23,29].	  Consequently,	  this	  means	  that	  the	  majority	  of	  studies	  use	  ATII	  cells,	  or	  ATI-­‐like	  cells	  (which	  are	  ATII	  cells	  which	  have	  been	  differentiated	  to	  express	  ATI	  phenotypic	  markers)[30,44].	  This	  raises	  a	  number	  of	  issues	  given	  that	  ATI	  cells	  are	  now	  implicated	  in	  more	  complex	  transport	  processes.	  Hence,	  it	  remains	  unclear	  whether	  the	  use	  of	  a	  single	  cell	  type	  can	  generate	  data	  that	  can	  accurately	  infer	  distinct	  ATI	  and	  ATII	  physiology.	  Johnson	  et	  al.	  raise	  these	  same	  concerns,	  as	  there	  is	  a	  marked	  difference	  in	  gene	  expression	  between	  cultured	  ATII	  and	  ATI	  cells[30].	  Thus,	  it	  is	  not	  surprising	  that	  the	  role	  of	  chloride	  transport	  in	  the	  alveoli	  remains	  unclear.	  However,	  identification	  of	  selective	  and	  non-­‐selective	  apical	  Na+	  channels	  (see	  “Lower	  respiratory	  tract”	  above),	  and	  K+	  channels	  (see	  “Potassium	  conductance”	  below)	  would	  suggest	  that	  the	  alveolar	  epithelium	  is	  primarily	  absorptive[30,32,33].	  	   Not	  all	  of	  the	  models	  that	  are	  currently	  used	  to	  study	  Cl-­‐	  transport	  require	  cell	  culture.	  Many	  studies	  take	  advantage	  of	  animal	  models	  (Mus	  musculus,	  Rattus	  
norvegicus,	  and	  Xenopus	  laevis	  are	  most	  common),	  which	  allow	  researchers	  to	  look	  at	  the	  interactions	  between	  different	  ion	  channels	  (i.e.,	  ENaC	  and	  CFTR)[61,94,96,97].	  These	  types	  of	  interactions	  may	  be	  important	  in	  elucidating	  the	  underlying	  mechanisms	  that	  drive	  fluid	  clearance	  after	  viral	  infection.	  Moreover,	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animal	  models	  provide	  a	  way	  to	  study	  longer-­‐term	  effects	  of	  viral	  infection,	  which	  are	  not	  necessarily	  feasible	  in	  vitro[61].	  	  	  
1.2.2.3.	  Secretion	  or	  absorption	  in	  the	  alveoli	  	   As	  outlined	  above,	  the	  variability	  in	  cell	  models	  likely	  impacts	  the	  ability	  to	  accurately	  determine	  the	  role	  that	  chloride	  channels	  play	  in	  regulating	  fluid	  levels	  in	  the	  alveoli.	  Studies	  involving	  freshly	  isolated	  Xenopus	  laevis	  lung	  epithelium	  have	  shown	  that	  under	  basal	  conditions,	  there	  is	  a	  net	  secretion	  of	  Cl-­‐[94].	  This	  model	  was	  chosen,	  as	  it	  demonstrates	  some	  similarities	  to	  mammalian	  alveolar	  epithelium[94].	  However,	  it	  should	  be	  noted	  that	  in	  this	  study,	  there	  was	  evidence	  to	  support	  the	  presence	  a	  Cl-­‐	  channel,	  in	  addition	  to	  CFTR,	  which	  may	  contribute	  to	  the	  net	  secretion[94].	  Additional	  evidence	  to	  support	  the	  observation	  that	  Cl-­‐	  secretion	  occurs	  in	  the	  lower	  airways	  is	  discussed	  by	  Brochiero	  et	  al.,	  although	  it	  is	  stated	  that	  the	  exact	  site	  of	  secretion	  is	  not	  clear	  at	  this	  point[22].	  Other	  studies	  performed	  using	  ATII	  cells	  (grown	  in	  an	  air-­‐liquid	  interface)	  have	  indicated	  that	  the	  CFTR	  gene	  is	  present	  in	  the	  apical	  membrane[22,37].	  Under	  basal	  conditions,	  it	  appears	  that	  fluid	  absorption	  is	  mostly	  driven	  through	  ENaC[37,98].	  Highly	  active	  Na+	  absorption	  will	  depolarize	  the	  cell,	  favoring	  absorption	  of	  Cl-­‐	  through	  CFTR,	  upon	  stimulation	  with	  cAMP[37].	  This	  absorptive	  characteristic	  appears	  to	  be	  dependent	  on	  the	  relative	  amounts	  of	  active	  ENaC	  present	  in	  the	  apical	  membrane[37].	  Interestingly,	  it	  has	  also	  been	  shown	  that	  ATII	  cells	  grown	  in	  an	  air-­‐liquid	  interface	  express	  higher	  amounts	  of	  active	  ENaC	  than	  those	  grown	  on	  submerged	  supports[38].	  In	  general,	  an	  increase	  in	  active	  ENaC	  creates	  a	  drive	  for	  Cl-­‐	  absorption	  across	  the	  apical	  membrane	  in	  order	  to	  satisfy	  conditions	  of	  electroneutrality[37,38].	  Additionally,	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the	  model	  proposed	  by	  Johnson	  et	  al.	  indicates	  that	  ATI	  cells,	  in	  particular,	  contain	  multiple	  sodium	  channels	  (both	  selective	  and	  non-­‐selective),	  further	  suggesting	  an	  absorptive	  phenotype	  in	  the	  lower	  airways[30,32]	  There	  is	  more	  evidence	  supporting	  the	  lower	  respiratory	  tract	  as	  having	  an	  absorptive	  phenotype	  than	  a	  secretory	  phentoype	  suggesting	  that	  the	  general	  movement	  of	  chloride	  on	  the	  apical	  membrane	  is	  inward[31,32,36].	  	   Studies	  using	  mouse	  tracheal	  epithelium	  show	  that	  during	  the	  initial	  stages	  of	  influenza	  infection	  there	  is	  no	  impact	  on	  chloride	  conductance[60].	  However,	  according	  to	  Wolk	  et	  al.,	  after	  2	  days	  of	  infection	  with	  influenza	  virus,	  there	  was	  an	  observed	  increase	  in	  Cl-­‐	  secretion[61].	  Hence,	  active	  viral	  replication	  is	  required	  in	  order	  to	  observe	  an	  effect	  on	  chloride	  conductance.	  The	  mechanism	  proposed	  by	  Wolk	  et	  al.	  involves	  the	  conversion	  of	  ATP	  into	  adenosine,	  which	  subsequently	  activates	  its	  receptor	  (A1-­‐subtype	  adenosine	  receptor)	  and	  stimulates	  the	  secretion	  of	  Cl-­‐	  through	  CFTR[61].	  Moreover,	  it	  was	  also	  mentioned	  that	  UTP	  acts	  to	  increase	  Cl-­‐	  secretion,	  likely	  mediated	  through	  TMEM16A,	  in	  addition	  to	  decreasing	  Na+	  absorption[61,81].	  The	  combination	  of	  these	  actions	  would	  result	  in	  increased	  fluid	  in	  the	  lungs.	  	  	   Undoubtedly,	  Cl-­‐	  transport	  is	  heavily	  involved	  in	  the	  regulation	  of	  lung	  fluid	  homeostasis,	  and	  it	  seems	  that	  understanding	  the	  complex	  interactions	  that	  occur	  between	  cells	  in	  order	  to	  up-­‐	  or	  down-­‐regulate	  ion	  channels	  will	  remain	  an	  area	  of	  interest.	  These	  types	  of	  studies	  remain	  important,	  given	  that	  respiratory-­‐associated	  infections	  and	  diseases	  afflict	  a	  large	  number	  of	  individuals	  each	  year.	  The	  above	  information	  demonstrates	  that	  influenza	  virus	  works	  on	  two	  levels	  to	  directly	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modulate	  ion	  transport	  processes	  in	  respiratory	  epithelial	  cells	  to	  cause	  pulmonary	  edema.	  Initially,	  Na+	  absorption	  is	  decreased	  by	  binding	  of	  the	  virus	  to	  its	  cellular	  receptor;	  secondary	  to	  that,	  Cl-­‐	  conductance	  is	  modified	  by	  later	  stages	  of	  infection	  that	  involve	  viral	  replication	  (Figure	  5)[60,61,62].	  	  
1.2.3.	  Potassium	  conductance	  	   Although	  potassium	  conductance	  is	  essential	  for	  driving	  the	  movement	  of	  fluid	  in	  the	  airways,	  the	  impact	  influenza	  infection	  on	  this	  important	  process	  has	  not	  been	  studied.	  The	  movement	  of	  potassium	  (K+)	  out	  of	  epithelial	  cells	  hyperpolarizes	  the	  membrane,	  creating	  a	  drive	  for	  the	  apical	  secretion	  of	  chloride[65,87,88,89,99].	  In	  the	  upper	  airways,	  fluid	  secretion	  depends	  heavily	  on	  the	  ability	  to	  drive	  chloride	  across	  the	  apical	  membrane[11,12].	  The	  main	  driving	  force	  for	  this	  movement	  of	  chloride	  is	  dependent	  on	  potassium	  channel	  activity,	  previously	  believed	  to	  exist	  only	  basolaterally[100,101].	  However,	  more	  recent	  studies	  have	  indicated	  that	  both	  apical	  and	  basolateral	  K+	  channels	  are	  present,	  and	  play	  a	  role	  in	  regulating	  fluid	  secretion[88].	  In	  Calu3	  cells,	  the	  presence	  of	  the	  basolateral	  K+	  channel,	  KCNN4,	  has	  been	  shown,	  along	  with	  several	  apical	  K+	  channels	  (KCNQ	  family	  and	  K2P)[65,87,89,100].	  	  	   KCNN4	  is	  a	  calcium-­‐activated	  potassium	  channel,	  which	  is	  primarily	  localized	  to	  the	  basolateral	  membrane	  of	  airway	  epithelial	  cells[65].	  Increases	  in	  intracellular	  calcium	  stimulate	  the	  efflux	  of	  K+	  from	  this	  channel.	  As	  proposed	  by	  McCann	  et	  al.,	  stimulation	  of	  tracheal	  cells	  with	  cAMP,	  in	  addition	  to	  increasing	  anion	  secretion	  through	  CFTR	  directly,	  will	  also	  increase	  cytosolic	  calcium	  concentrations[102].	  This	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Figure	  5.	  Direct	  impact	  of	  influenza	  virus	  infection	  on	  respiratory	  epithelial	  
cell	  ion	  transport.	  Simplified	  diagram	  showing	  the	  direct	  impact	  influenza	  virus	  infection	  has	  on	  ion	  transport	  processes.	  A)	  Short-­‐term	  infection	  (after	  1	  hour)	  with	  influenza	  virus	  results	  in	  modulation	  of	  ENaCs	  via	  PKC	  activation	  (see	  Figures	  3,	  4).	  This	  initial	  binding	  of	  the	  virus	  to	  its	  cellular	  receptor	  leads	  to	  decreased	  ENaC	  activity	  (see	  text	  for	  further	  details).	  B)	  Longer-­‐term	  infection	  involves	  active	  viral	  replication,	  which	  has	  been	  shown	  to	  stimulate	  secretion	  of	  Cl-­‐	  across	  the	  apical	  membrane	  (see	  text).	  The	  combination	  of	  these	  events	  prevents	  H2O	  from	  being	  reabsorbed,	  leading	  to	  a	  buildup	  of	  fluid	  in	  the	  airspace	  (i.e.,	  pulmonary	  edema).	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will,	  in	  turn,	  activate	  basolateral	  potassium	  conductance	  and	  further	  drive	  apical	  anion	  secretion[100,102].	  	  	   This	  model	  of	  recycling	  of	  potassium	  across	  the	  basolateral	  membrane	  (entry	  via	  Na+-­‐K+-­‐ATPase	  pump,	  exit	  through	  KCNN4)	  is	  based	  upon	  work	  done	  by	  Silva	  et	  
al.	  in	  shark	  rectal	  glands[103].	  However,	  more	  recent	  evidence	  suggests	  a	  role	  for	  apically	  located	  K+	  channels	  in	  driving	  anion	  secretion[87,88,89,91,104].	  Cook	  et	  al.	  describes	  apical	  anion	  secretion	  being	  enhanced	  by	  the	  presence	  of	  active,	  apical	  K+	  channels[104].	  Further	  work	  has	  been	  done	  in	  Calu3	  and	  NHBE	  cells	  on	  the	  KCNQ	  family	  of	  cAMP-­‐activated	  K+	  channels,	  as	  well	  as	  the	  two-­‐pore	  K+	  channels	  (K2P),	  both	  of	  which	  are	  shown	  the	  be	  located	  in	  the	  apical	  membrane[87,88,89,91].	  	   The	  KCNQ	  family	  of	  K+	  channels	  includes	  KCNQ1-­‐5,	  which	  are	  cAMP-­‐activated[89].	  KCNQ1,	  in	  particular,	  is	  comprised	  of	  two	  subunits:	  KCNE2	  and	  KCNE3[89,91].	  Studies	  done	  in	  Calu3	  cells	  indicate	  that	  KCNQ1	  is	  present	  in	  both	  the	  apical	  and	  basolateral	  membrane,	  and	  contributes	  to	  the	  overall	  drive	  for	  apical	  anion	  secretion[65,89].	  Cowley	  et	  al.	  describe	  KCNQ1	  as	  a	  potential	  contributor,	  along	  with	  KCNN4,	  to	  the	  overall	  anion	  secretion	  in	  Calu3	  cells;	  however,	  they	  failed	  to	  detect	  mRNA	  expression	  of	  both	  KCNQ1	  subunits[65].	  Moser	  et	  al.	  proposes	  that	  the	  ability	  of	  KCNQ1	  to	  generate	  a	  cAMP-­‐stimulated	  current	  is	  highly	  dependent	  on	  its	  association	  with	  both	  KCNE2/3[89].	  Additionally,	  Moser	  et	  al.	  describes	  a	  larger	  role	  for	  other	  KCNQ	  family	  channels,	  namely	  KCNQ3	  and	  KCNQ5,	  to	  the	  apical	  K+	  conductance	  observed	  in	  Calu3	  cells[89].	  It	  appears	  that	  Calu3	  cells	  contain	  several	  different	  KCNQ	  channels,	  and	  that	  their	  expression	  levels	  may	  vary	  between	  cultures[89].	  Additionally,	  studies	  in	  both	  Calu3	  and	  NHBE	  cells	  indicate	  the	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presence	  of	  a	  two-­‐pore	  K+	  channel	  (K2P)	  located	  in	  the	  apical	  membrane[87,88].	  The	  primary	  role	  of	  these	  K2P	  channels,	  and	  KCNQ1,	  is	  in	  maintaining	  hyperpolarizing	  conditions	  at	  the	  apical	  membrane	  in	  order	  to	  sustain	  chloride	  secretion[88].	  The	  constant	  efflux	  of	  potassium,	  either	  through	  apical	  or	  basolateral	  channels,	  maintains	  the	  necessary	  negative	  membrane	  potential	  to	  drive	  secretion	  in	  the	  upper	  airways.	  	   Influenza	  virus	  infection	  has	  been	  studied	  with	  regards	  to	  sodium	  and	  chloride	  ion	  transport;	  however,	  the	  effects	  on	  potassium	  conductance	  have	  yet	  to	  be	  addressed[60,61,62].	  Clearly,	  the	  role	  of	  potassium	  conductance	  in	  the	  overall	  process	  of	  fluid	  secretion	  cannot	  be	  ignored,	  as	  they	  are	  inextricably	  linked.	  Research	  in	  this	  area	  may	  uncover	  potentially	  new	  drug	  targets	  for	  influenza-­‐associated	  complications,	  like	  pulmonary	  edema.	  	  
1.3.	  Indirect	  effects	  of	  influenza	  on	  epithelial	  cell	  ion	  channel	  physiology	  
1.3.1.	  Activation	  of	  the	  innate	  immune	  system	  	   The	  innate	  immune	  system	  acts	  as	  the	  first	  line	  of	  defense	  against	  any	  invading	  pathogens[13].	  In	  the	  lungs,	  as	  previously	  mentioned,	  the	  ability	  to	  effectively	  clear	  the	  ASL	  and	  any	  trapped	  pathogens	  aid	  in	  defending	  against	  infections.	  This	  system	  is	  the	  primary	  defense	  mechanism;	  however,	  both	  epithelial	  cells	  and	  macrophages	  have	  the	  ability	  to	  further	  protect	  against	  invading	  pathogens	  through	  the	  production	  of	  cytokines[10,19].	  Resident	  macrophages	  of	  the	  lungs	  are	  of	  critical	  importance	  in	  alerting	  the	  immune	  system	  during	  viral	  infections[46].	  Macrophages	  are	  capable	  of	  phagocytosing	  invading	  pathogens,	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which,	  in	  turn,	  activate	  them[13].	  Upon	  activation,	  macrophages	  secrete	  several	  different	  pro-­‐inflammatory	  cytokines,	  including	  TNF-­‐α[46,47,105].	  TNF-­‐α	  is	  an	  important	  immune	  mediator,	  which	  is	  also	  produced	  by	  epithelial	  cells,	  and	  acts	  to	  recruit	  additional	  immune	  cells	  to	  the	  site	  of	  infection[47,48].	  Additionally,	  TNF-­‐α	  induces	  the	  secretion	  of	  other	  pro-­‐inflammatory	  cytokines	  such	  as	  IL-­‐6,	  IL-­‐8	  and	  IL-­‐1α/β[48,106].	  Together,	  these	  cytokines	  act	  to	  enhance	  the	  inflammatory	  response	  in	  the	  host[5,49].	  However,	  certain	  cytokines	  have	  been	  shown	  to	  modulate	  ion	  transport	  processes,	  exacerbating	  the	  overall	  effect	  influenza	  virus	  has	  on	  respiratory	  epithelium[48,58,107,108,109].	  	  	   Macrophages	  are	  not	  the	  only	  cells	  involved	  in	  stimulation	  of	  the	  innate	  immune	  response.	  In	  fact,	  the	  respiratory	  epithelial	  cells	  themselves	  are	  equipped	  with	  the	  ability	  to	  recognize	  PAMPs	  through	  a	  variety	  of	  different	  PRRs[53,54].	  The	  most	  common	  PRRs	  involved	  in	  viral	  recognition	  include	  TLRs	  and	  RLRs	  (Figure	  6)[52,53].	  More	  specifically,	  TLR3	  and	  TLR7	  (located	  inside	  endosomes)	  have	  been	  implicated	  in	  recognition	  of	  influenza	  virus,	  as	  these	  receptors	  primarily	  recognize	  double-­‐stranded	  and	  single-­‐stranded	  RNA,	  respectively[49,53,55].	  Furthermore,	  recognition	  of	  viral	  RNA	  in	  the	  cytoplasm	  is	  achieved	  through	  RIG-­‐I[49,53,54].	  The	  influenza	  virus	  RNA	  contains	  an	  uncapped	  5’-­‐triphosphate,	  and	  RIG-­‐I	  has	  been	  shown	  to	  directly	  interact	  with	  this	  type	  of	  RNA[110].	  Regardless	  of	  how	  influenza	  virus	  is	  recognized	  in	  the	  cell,	  there	  is	  initiation	  of	  signaling	  pathways	  which	  result	  in	  production	  of	  type	  I	  interferons	  (IFNs),	  as	  well	  as	  activation	  of	  NF-­‐kB[54,55].	  	  	   Type	  I	  IFNs	  include	  IFN-­‐α	  and	  IFN-­‐β;	  the	  expression	  of	  type	  I	  IFNs	  is	  critical	  in	  inducing	  an	  antiviral	  state	  inside	  the	  cell[49].	  Induction	  of	  type	  I	  IFNs	  also	  aids	  in	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the	  recruitment	  of	  various	  immune	  mediators	  such	  as	  dendritic	  cells	  and	  natural	  killer	  cells,	  which	  act	  to	  enhance	  the	  immune	  response[53,111].	  Interestingly,	  influenza	  virus	  has	  some	  capacity	  to	  defend	  against	  type	  I	  IFN	  production.	  A	  study	  done	  by	  Kochs	  et	  al.	  has	  indicated	  that	  the	  non-­‐structural	  protein,	  NS1,	  is	  able	  to	  antagonize	  the	  production	  of	  type	  I	  IFNs[112,113].	  Further	  actions	  taken	  by	  the	  host	  innate	  immune	  response	  include	  activation	  of	  NF-­‐kB.	  The	  NF-­‐kB	  pathway	  is	  responsible	  for	  inducing	  the	  production	  of	  pro-­‐inflammatory	  cytokines[52,53].	  Overall,	  the	  recognition	  of	  viral	  PAMPs	  initiates	  fundamental	  pathways	  involved	  in	  limiting	  the	  spread	  of	  the	  virus.	  Interruptions	  to	  this	  process,	  mainly	  though	  interference	  by	  the	  virus	  itself	  can	  result	  in	  a	  reduced	  ability	  to	  clear	  the	  infection.	   	  
1.3.1.1.	  Role	  of	  pro-­‐inflammatory	  cytokines	  	   An	  important	  component	  of	  the	  innate	  immune	  response	  is	  mediated	  through	  the	  production	  of	  pro-­‐inflammatory	  cytokines,	  namely	  TNF-­‐α,	  IFN-­‐α/β,	  IL-­‐6,	  IL-­‐8,	  RANTES	  and	  IL-­‐1β[13].	  There	  is	  evidence	  to	  support	  that	  infection	  of	  airway	  epithelial	  cells	  with	  influenza	  virus	  results	  in	  a	  strong	  pro-­‐inflammatory	  cytokine	  response[5,106,114].	  These	  cytokines,	  although	  important	  in	  limiting	  the	  spread	  of	  the	  virus,	  can	  also	  contribute	  to	  the	  overall	  pathogenicity	  of	  the	  infection[13,56,115].	  Work	  done	  by	  Matsukura	  et	  al.,	  has	  indicated	  that	  human	  bronchial	  epithelial	  cells	  infected	  with	  influenza	  virus	  show	  increased	  expression	  of	  IL-­‐6,	  IL-­‐8	  and	  RANTES	  (Regulated	  on	  Activation,	  Normal	  T	  cell	  Expressed	  and	  Secreted)[56].	  They	  further	  state	  that	  these	  cytokines	  may	  be	  contributing	  to	  the	  overall	  pathogenesis	  of	  influenza-­‐induced	  airway	  inflammation[56,115].	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Figure	  6.	  Outline	  of	  how	  epithelial	  cells	  recognize	  viral	  PAMPs.	  
Upon	  recognition	  of	  viral	  nucleic	  acid	  (dsRNA/ssRNA)	  either	  in	  the	  cytoplasm	  or	  inside	  endosomes,	  the	  innate	  immune	  system	  becomes	  activated.	  TLR3	  and	  TLR7	  are	  present	  inside	  endosomes,	  and	  recognize	  viral	  dsRNA	  and	  ssRNA,	  respectively.	  In	  the	  cytoplasm,	  uncapped	  5’-­‐triphosphate	  ssRNA	  is	  recognized	  by	  RIG-­‐I.	  These	  pattern	  recognition	  receptors	  (PRRs)	  use	  different	  signaling	  pathways	  in	  order	  to	  induce	  an	  antiviral	  state,	  and	  recruit	  dendritic	  cells	  and	  natural	  killer	  cells	  through	  activation	  of	  type	  I	  interferons	  (IFNs).	  Pro-­‐inflammatory	  cytokines	  are	  produced	  through	  the	  NF-­‐kB	  pathway.	  Together,	  these	  components	  of	  the	  innate	  immune	  system	  aid	  in	  fighting	  viral	  infection.	  	  	  	  	  	  
	   29	  
In	  addition	  to	  this,	  studies	  have	  indicated	  that	  production	  of	  TNF-­‐α	  and	  IL-­‐1β	  are	  also	  increased	  during	  infection	  with	  influenza,	  and	  are	  found	  in	  edema	  fluid[48,116,117].	  These	  inflammatory	  mediators	  have	  been	  implicated	  in	  regulating	  the	  ion	  transport	  processes	  in	  the	  airways[48,59,117,118].	  	   Interleukin	  1β	  (IL-­‐1β)	  is	  considered	  to	  be	  one	  of	  the	  most	  biologically	  relevant	  inflammatory	  cytokines,	  especially	  in	  the	  context	  of	  edema	  formation	  in	  the	  lung[117].	  Induction	  of	  IL-­‐1β	  is	  associated	  with	  airway	  inflammation,	  and	  can	  be	  produced	  by	  a	  number	  of	  different	  cell	  types,	  including	  epithelial	  cells[59,119].	  Moreover,	  IL-­‐1β	  has	  been	  implicated	  as	  an	  inflammatory	  mediator	  that	  may	  directly	  impact	  ion	  transport	  processes	  in	  airway	  epithelial	  cells[59,117].	  A	  study	  performed	  using	  human	  bronchial	  epithelium	  shows	  that	  after	  48	  hours	  of	  IL-­‐1β	  treatment,	  there	  is	  a	  significant	  increase	  in	  basal	  currents,	  indicating	  there	  is	  a	  concerted	  effect	  on	  Na+	  absorption	  and	  CFTR-­‐dependent	  Cl-­‐	  secretion[59].	  This	  was	  further	  substantiated	  through	  direct	  measurement	  of	  ASL	  levels,	  which	  were	  increased	  after	  treatment	  with	  IL-­‐1β[59].	  Gray	  et	  al.	  has	  shown	  that	  long-­‐term	  exposure	  to	  IL-­‐1β	  results	  in	  a	  reduced	  ability	  to	  actively	  clear	  fluid	  from	  the	  airways,	  therefore	  contributing	  to	  the	  formation	  of	  lung	  edema.	  Complementary	  to	  this	  phenomenon,	  a	  study	  done	  using	  alveolar	  epithelial	  cells	  shows	  that	  IL-­‐1β	  causes	  a	  decrease	  in	  
αENaC	  mRNA	  and	  protein	  levels	  in	  a	  dose-­‐dependent	  manner[117].	  This	  effect	  was	  observed	  as	  early	  as	  6	  hours	  after	  treatment,	  and	  was	  ameliorated	  by	  pre-­‐treatment	  with	  a	  receptor	  antagonist	  against	  IL-­‐1β[117].	  Upon	  further	  investigation	  into	  the	  specific	  mechanism,	  it	  was	  discovered	  that	  down-­‐regulation	  of	  αENaC	  protein	  is	  mediated	  through	  the	  p38	  MAPK	  signaling	  pathway[117].	  This	  evidence	  supports	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IL-­‐1β	  as	  a	  key	  modulator	  of	  Na+	  transport	  during	  airway	  inflammation.	  	   Several	  studies	  have	  already	  addressed	  the	  role	  TNF-­‐α	  plays	  in	  modulating	  Na+	  transport	  processes	  in	  respiratory	  epithelium[48,118,120].	  However,	  the	  exact	  role	  that	  this	  inflammatory	  cytokine	  plays	  in	  relation	  to	  Na+	  absorption	  is	  still	  under	  debate.	  A	  study	  that	  looked	  at	  Cl-­‐	  transport	  have	  shown	  that	  TNF-­‐α	  is	  capable	  of	  modulating	  CFTR	  gene	  expression	  in	  a	  time	  and	  dose-­‐dependent	  manner[120].	  	  However,	  this	  study	  was	  performed	  using	  colon-­‐derived	  epithelial	  cells,	  and	  therefore	  cannot	  be	  directly	  compared	  to	  respiratory	  epithelium.	  Work	  done	  by	  Fukuda	  et	  al.	  in	  alveolar	  epithelium	  has	  shown	  that	  immediately	  after	  the	  addition	  of	  TNF-­‐α	  there	  is	  an	  observed	  increase	  in	  Na+	  transport[118].	  They	  rationalize	  that	  this	  increased	  ability	  to	  transport	  Na+	  will	  lead	  to	  up-­‐regulation	  of	  fluid	  clearance	  in	  the	  lung	  via	  ENaC[118].	  Contrary	  to	  this,	  Dagenais	  et	  al.	  has	  shown	  that	  over	  a	  24-­‐hour	  period	  exposure	  to	  TNF-­‐α	  results	  in	  a	  significant	  decrease	  in	  ENaC	  mRNA	  expression	  (α,	  β,	  and	  γ	  subunits)	  relative	  to	  untreated	  controls[48].	  A	  decrease	  in	  apical	  ENaCs	  will	  lead	  to	  a	  decreased	  ability	  to	  clear	  fluid	  from	  the	  airways.	  These	  two	  studies	  imply	  very	  different	  outcomes	  for	  individuals	  suffering	  from	  influenza	  infection	  where	  expression	  of	  TNF-­‐α	  has	  been	  shown	  to	  be	  increased.	  It	  seems	  likely	  that	  the	  data	  from	  the	  latter	  study	  are	  a	  better	  representation	  of	  what	  occurs	  in	  a	  natural	  infection,	  given	  that	  cytokines,	  like	  TNF-­‐α,	  will	  be	  expressed	  for	  longer	  than	  the	  short	  time	  period	  assessed	  by	  the	  former	  study.	  Assuming	  that	  TNF-­‐α	  does	  exacerbate	  edema	  formation	  during	  influenza	  virus	  infection,	  further	  investigation	  of	  the	  underlying	  mechanism	  may	  prove	  useful	  in	  the	  development	  of	  new	  drug	  therapies.	  Since	  TNF-­‐α	  in	  particular	  is	  an	  important	  component	  of	  the	  innate	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immune	  response,	  a	  targeted	  drug	  therapy	  may	  have	  universal	  applications	  that	  would	  extend	  beyond	  influenza	  virus	  infections.	  	   Other	  cytokines	  that	  have	  been	  implicated	  in	  the	  modulation	  of	  both	  ENaC	  and	  CFTR	  in	  bronchial	  epithelial	  cells	  include	  IL-­‐13,	  IL-­‐4	  and	  IFN-­‐γ[107,108,109].	  IL-­‐13	  and	  IL-­‐4	  are	  both	  Th2	  cytokines,	  secreted	  in	  response	  to	  inflammation[108,109].	  Cells	  dosed	  for	  48	  hours	  with	  IL-­‐13	  or	  IL-­‐4	  decreased	  sodium	  absorption,	  and	  increased	  both	  cAMP-­‐	  and	  calcium-­‐activated	  chloride	  secretion[109].	  Further	  studies	  done	  by	  Galietta	  et	  al.,	  indicate	  that	  IL-­‐4	  treatment	  down-­‐regulates	  γENaC	  mRNA	  expression,	  accounting	  for	  the	  decreased	  sodium	  absorption[108].	  Additionally,	  the	  observed	  increase	  in	  cAMP-­‐dependent	  current,	  mediated	  by	  IL-­‐4,	  was	  shown	  to	  be	  a	  result	  of	  increased	  CFTR	  mRNA	  expression[108].	  IL-­‐4	  was	  capable	  of	  eliciting	  an	  increase	  in	  the	  calcium-­‐dependent	  current	  after	  only	  6	  hours	  of	  treatment;	  however,	  the	  underlying	  mechanism	  that	  drives	  this	  up-­‐regulation	  was	  not	  addressed[108].	  IL-­‐13	  acts	  on	  the	  same	  epithelial	  receptor	  as	  IL-­‐4,	  so	  although	  the	  details	  of	  how	  IL-­‐13	  works	  to	  induce	  hypersecretion	  in	  the	  airways	  were	  not	  directly	  addressed,	  it	  is	  likely	  that	  they	  work	  through	  a	  similar	  mechanism[108,109].	  	  	   Interestingly,	  treatment	  of	  human	  bronchial	  epithelial	  cells	  with	  IFN-­‐γ,	  which	  is	  produced	  in	  response	  to	  viral	  infection	  and	  contributes	  to	  the	  overall	  inflammatory	  response,	  resulted	  in	  down-­‐regulation	  of	  cAMP-­‐dependent	  chloride	  transport,	  but	  up-­‐regulation	  of	  calcium-­‐dependent	  chloride	  transport[107].	  Galietta	  
et	  al.	  attribute	  the	  reduction	  in	  cAMP-­‐dependent	  transport	  to	  a	  down-­‐regulation	  of	  CFTR	  mRNA,	  and	  suggest	  that	  IFN-­‐γ	  may	  be	  acting	  directly	  on	  CaCCs	  to	  up-­‐regulate	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their	  activity[107].	  Treatment	  with	  IFN-­‐γ	  for	  48	  hours	  also	  reduced	  sodium	  absorption;	  however,	  there	  were	  no	  changes	  in	  ENaC	  mRNA[107,108].	  Speculation	  in	  a	  follow	  up	  study	  indicates	  that	  ENaC	  is	  likely	  modulated	  through	  an	  alternative	  mechanism	  that	  has	  yet	  to	  be	  directly	  linked	  to	  IFN-­‐γ[108].	  	  	   The	  evidence	  presented	  here	  indicates	  that	  influenza	  virus	  is	  capable	  of	  indirectly	  modulating	  both	  Na+	  and	  Cl-­‐	  transport	  through	  activation	  of	  the	  innate	  immune	  system	  (Figure	  7).	  Production	  of	  various	  inflammatory	  mediators,	  such	  as	  TNF-­‐α,	  IL-­‐1β,	  and	  IFN-­‐γ,	  play	  a	  significant	  role	  in	  fighting	  against	  viral	  infection,	  and	  the	  initiation	  of	  the	  inflammatory	  response	  leads	  to	  anti-­‐inflammatory	  cytokine	  production	  (i.e.,	  IL-­‐13,	  IL-­‐4).	  However,	  these	  cytokines	  have	  the	  potential	  to	  exacerbate	  the	  damage	  caused	  by	  the	  infection	  through	  further	  modulation	  of	  ion	  transport	  processes.	  In	  addition	  to	  this,	  the	  pro-­‐inflammatory	  cytokines	  recruit	  immune	  cells	  to	  the	  site	  of	  infection;	  infiltration	  of	  these	  cells	  causes	  inflammation,	  which,	  in	  the	  long	  term,	  will	  compromise	  the	  epithelial	  cell	  barrier[115].	  Together,	  increased	  cellular	  permeability	  in	  conjunction	  with	  disrupted	  ion	  transport	  results	  in	  severe	  edema	  formation,	  and	  damage	  to	  the	  lungs.	  	  
1.4.	  Lung	  pathology	  
1.4.1.	  Epithelial	  cell	  damage	  	   Given	  that	  influenza	  virus	  infections	  often	  lead	  to	  complications	  such	  as	  pulmonary	  edema,	  and	  pneumonia	  (discussed	  above),	  it	  is	  not	  surprising	  that	  the	  lungs	  themselves	  suffer	  extensive	  damage.	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Figure	  7.	  Overview	  of	  the	  indirect	  impact	  of	  influenza	  virus	  infection	  on	  ion	  
transport	  processes.	  Pro-­‐inflammatory	  cytokines	  produced	  by	  epithelial	  cells	  infected	  with	  influenza	  virus	  can	  act	  on	  neighboring	  cells	  to	  modulate	  ion	  transport.	  A)	  Epithelial	  ion	  transport	  at	  homeostasis	  (simplified	  from	  figure	  1).	  Initially,	  virus	  infection	  alters	  ENaC,	  reducing	  the	  ability	  to	  reabsorb	  Na+	  (see	  text,	  and	  figures	  3,	  4).	  There	  is	  no	  observed	  effect	  on	  chloride	  secretion	  upon	  initial	  infection.	  B)	  Longer-­‐term	  impact.	  After	  viral	  replication	  begins,	  there	  is	  an	  up-­‐regulation	  of	  apical	  Cl-­‐	  secretion.	  Epithelial	  cells	  begin	  secreting	  pro-­‐inflammatory	  cytokines	  and	  evoke	  the	  innate	  immune	  response	  (involves	  activation	  of	  macrophages,	  which	  contribute	  to	  the	  pro-­‐inflammatory	  response).	  Although	  many	  different	  cytokines,	  both	  pro-­‐	  and	  anti-­‐inflammatory,	  are	  produced,	  TNF-­‐α,	  IL-­‐1β,	  and	  IL-­‐4	  have	  the	  capacity	  to	  further	  down-­‐regulate	  ENaC	  (see	  text	  for	  details).	  IL-­‐1β	  and	  IL-­‐4	  may	  also	  be	  involved	  in	  up-­‐regulating	  CFTR,	  whereas	  IFN-­‐γ	  has	  been	  shown	  to	  modulate	  calcium-­‐activated	  chloride	  channels.	  Altogether,	  this	  leads	  to	  a	  reduced	  ability	  to	  clear	  fluid	  from	  the	  airspace,	  resulting	  in	  pulmonary	  edema.	  Recruitment	  of	  additional	  immune	  cells	  to	  the	  site	  of	  infection	  leads	  to	  further	  inflammation,	  which	  contributes	  to	  cellular	  damage	  in	  the	  lungs.	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  The	  damage	  caused	  by	  infection	  is	  a	  result	  of	  both	  the	  cytopathic	  effect	  of	  the	  virus,	  combined	  with	  the	  inflammatory	  response	  of	  the	  host[7].	  The	  NS1	  viral	  protein	  has	  been	  implicated	  as	  a	  major	  contributing	  factor	  to	  the	  overall	  pathogenesis	  of	  influenza[113,121].	  One	  study	  identified	  that	  NS1	  is	  likely	  to	  be	  involved	  in	  the	  induction	  of	  pro-­‐inflammatory	  cytokines	  in	  addition	  to	  stimulating	  strong	  apoptotic	  responses[121].	  The	  induction	  of	  apoptosis,	  along	  with	  a	  strong	  inflammatory	  response	  has	  major	  implications	  for	  disease	  severity[105,121].	  In	  general,	  fatal	  cases	  of	  influenza	  virus	  infection	  require	  movement	  of	  the	  virus	  into	  the	  lower	  respiratory	  tract[3,7].	  Those	  individuals	  infected	  only	  in	  the	  upper	  respiratory	  tract	  develop	  clinical	  symptoms	  such	  as	  bronchitis,	  whereas	  more	  severe	  cases	  with	  lower	  respiratory	  tract	  involvement	  can	  result	  in	  diffuse	  alveolar	  damage,	  which	  can	  lead	  to	  fatal	  respiratory	  dysfunction[3,7,35].	  	  	   In	  acute	  stages	  of	  infection,	  there	  is	  a	  large	  degree	  of	  variability	  in	  structural	  damage	  to	  the	  epithelium.	  A	  common	  theme,	  however,	  is	  desquamation	  of	  epithelial	  cells,	  as	  well	  as	  apoptosis	  and	  necrosis[3,105].	  As	  the	  infection	  progresses,	  both	  macrophages	  and	  neutrophils	  begin	  to	  infiltrate	  the	  airspace;	  these	  cells	  will	  phagocytose	  the	  apoptotic	  and	  necrotic	  epithelial	  cells[7,105].	  Furthermore,	  the	  development	  of	  viral	  pneumonia	  is	  associated	  with	  alveolar	  hemorrhaging	  and	  necrotizing	  bronchiolitis[3,114].	  Additional	  complications	  include	  secondary	  bacterial	  infections,	  which	  aggravate	  the	  inflammatory	  response,	  leading	  to	  further	  infiltration	  of	  neutrophils[3].	  	  	   The	  majority	  of	  studies	  looking	  at	  lung	  pathology	  occur	  in	  individuals	  who	  have	  succumbed	  to	  complications,	  making	  it	  difficult	  to	  ascertain	  the	  damage	  caused	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in	  the	  initial	  stages	  of	  the	  infection.	  	  It	  is	  important	  to	  note	  that	  the	  severity	  of	  influenza	  virus	  infections	  arises	  from	  a	  multitude	  of	  factors,	  both	  virus-­‐	  and	  host-­‐related.	  Additionally,	  not	  all	  of	  the	  cells	  in	  the	  airway	  will	  become	  infected	  with	  the	  virus,	  making	  the	  associated	  pathology	  a	  result	  of	  both	  virus	  and	  host	  factors.	  	  
1.5.	  Conclusion	  	   Influenza	  virus	  uses	  a	  multifaceted	  approach	  to	  cause	  disease	  in	  the	  airways.	  The	  virus	  acts	  directly	  on	  epithelial	  cells	  to	  alter	  the	  transport	  of	  Na+	  and	  Cl-­‐,	  at	  the	  ion	  channel	  level.	  As	  the	  infection	  progresses	  and	  viral	  replication	  ensues,	  a	  range	  of	  signaling	  pathways	  contribute	  to	  further	  disruption	  of	  ion	  transport.	  In	  general,	  there	  is	  an	  observed	  decrease	  in	  the	  ability	  to	  reabsorb	  Na+,	  along	  with	  an	  increase	  in	  Cl-­‐	  secretion.	  Potassium	  channels,	  which	  create	  the	  drive	  for	  chloride	  secretion,	  are	  likely	  involved;	  however,	  this	  area	  has	  yet	  to	  be	  studied.	  These	  processes	  impair	  the	  natural	  capacity	  of	  the	  lungs	  to	  reabsorb	  fluid	  from	  the	  airspace,	  resulting	  in	  pulmonary	  edema.	  The	  immune	  response	  of	  the	  host	  also	  contributes	  to	  this	  phenomenon,	  further	  exacerbating	  the	  situation.	  The	  combined	  effects	  of	  the	  virus	  and	  the	  host	  immune	  response	  often	  lead	  to	  fatal	  complications	  due	  to	  extensive	  lung	  damage.	  Further	  investigations	  into	  the	  complex	  mechanisms	  that	  underlie	  the	  pathophysiology	  are	  required	  to	  eliminate	  influenza-­‐associated	  fatalities.	  	  
1.6.	  Purpose	  	   Evidence	  indicates	  that	  influenza	  virus	  is	  capable	  of	  directly	  modulating	  both	  sodium	  and	  chloride	  ion	  channels	  in	  epithelial	  cells.	  Additionally,	  the	  pro-­‐inflammatory	  cytokines	  produced	  by	  the	  infected	  epithelial	  cells	  have	  been	  shown	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to	  have	  regulatory	  effects	  on	  these	  same	  ion	  channels.	  However,	  the	  effects	  of	  influenza	  virus	  infection	  have	  not	  yet	  been	  studied	  with	  respect	  to	  potassium	  ion	  channels.	  This	  is	  important	  because	  the	  movement	  of	  potassium	  out	  of	  the	  cell	  directly	  influences	  the	  movement	  of	  chloride	  and	  this	  process	  regulates	  airway	  hydration.	  The	  purpose	  of	  this	  study	  is	  to	  assess	  both	  the	  direct	  and	  indirect	  effects	  of	  influenza	  virus	  infection	  on	  potassium	  and	  chloride	  channel	  function	  in	  the	  secretory	  cell	  model,	  Calu3.	  	  
1.6.1	  Hypothesis	  	   The	  majority	  of	  the	  epithelium	  remains	  uninfected	  after	  initial	  exposure	  to	  influenza	  virus.	  The	  cells	  that	  have	  been	  infected	  will	  secrete	  both	  pro-­‐	  and	  anti-­‐inflammatory	  cytokines,	  which	  can	  act	  in	  a	  paracrine	  manner	  on	  the	  non-­‐infected	  cells.	  There	  is	  evidence	  showing	  that	  certain	  cytokines	  are	  capable	  of	  modulating	  ion	  channel	  function	  in	  respiratory	  epithelium.	  Therefore	  our	  hypothesis	  is	  that	  the	  inflammatory	  cytokine	  mixture	  secreted	  by	  epithelial	  cells	  during	  influenza	  virus	  infection	  is	  capable	  of	  modulating	  chloride	  and/or	  potassium	  ion	  channel	  function	  independently	  of	  the	  virus.	  In	  order	  to	  test	  this	  hypothesis,	  the	  direct	  and	  indirect	  effects	  of	  influenza	  virus	  infection	  were	  studied	  separately	  to	  determine	  whether	  the	  virus	  was	  required	  to	  modulate	  chloride	  and	  potassium	  ion	  channel	  function.	  
1.6.1.1.	  Specific	  objective	  1	  	  	   To	  determine	  if	  exposure	  of	  Calu3	  cells	  to	  influenza	  virus	  for	  24	  and	  48	  hours	  at	  a	  high	  dose	  (multiplicity	  of	  infection	  (MOI)	  of	  10)	  will	  modulate	  chloride	  and/or	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potassium	  ion	  channel	  function.	  We	  hypothesized	  that	  a	  high	  viral	  dose	  will	  decrease	  chloride	  and	  potassium	  ion	  channel	  conductance.	  
1.6.1.2.	  Specific	  objective	  2	  	  	   To	  determine	  a	  physiologically	  relevant	  dose	  (lower	  dose)	  of	  influenza	  virus	  that	  will	  induce	  an	  immune	  response	  and	  modulate	  ion	  channel	  physiology	  so	  as	  to	  model	  the	  symptoms	  observed	  in	  a	  natural	  infection,	  i.e.,	  pulmonary	  edema.	  	  We	  hypothesized	  that	  since	  not	  all	  of	  the	  cells	  in	  the	  respiratory	  tract	  are	  infected	  during	  a	  natural	  infection,	  a	  multiplicity	  of	  infection	  between	  0.1	  and	  1	  should	  be	  sufficient	  to	  model	  the	  effect	  of	  both	  virus,	  and	  cytokines	  together	  in	  vitro.	  	  
1.6.1.3.	  Specific	  objective	  3	  	  	   To	  determine	  whether	  the	  cytokines	  produced	  after	  48	  hours	  of	  infection	  are	  capable	  of	  independently	  modulating	  chloride	  and/or	  potassium	  ion	  channel	  function.	  We	  hypothesized	  that	  the	  mixture	  of	  cytokines	  produced	  during	  infection	  with	  influenza	  will	  cause	  an	  increase	  in	  chloride	  and/or	  potassium	  ion	  channel	  conductance.	  
1.6.1.4.	  Specific	  objective	  4	  	  	   To	  determine	  whether	  direct	  exposure	  to	  a	  single	  pro-­‐inflammatory	  cytokine,	  interleukin-­‐8	  (IL-­‐8)	  for	  48	  hours,	  will	  induce	  similar	  changes	  in	  chloride	  and	  potassium	  ion	  channel	  conductance	  as	  the	  cytokine	  mixture.	  Our	  hypothesis	  was	  that	  exposure	  to	  IL-­‐8	  for	  48	  hours	  will	  result	  in	  an	  increase	  in	  chloride	  and/or	  potassium	  ion	  channel	  function.	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CHAPTER	  2.	  MATERIALS	  AND	  METHODS	  
2.1.	  Cell	  culture	  
	   The	  human	  bronchial	  epithelial	  cell	  line,	  Calu3	  (HTB-­‐55;	  ATCC),	  was	  cultured	  at	  a	  low	  passage	  number	  in	  Dulbecco’s	  Modified	  Eagle	  Medium	  (DMEM,	  Invitrogen)	  supplemented	  with	  10%	  fetal	  bovine	  serum	  (FBS)	  (16000-­‐044;	  Life	  Technologies),	  1%	  Non-­‐essential	  amino	  acids	  (10	  mM,	  Invitrogen),	  1%	  Penicillin-­‐Streptomycin	  (Invitrogen),	  1%	  Sodium	  Pyruvate	  (Invitrogen),	  and	  1%	  L-­‐glutamine	  (200	  mM,	  Invitrogen)	  at	  37°C	  in	  a	  humidified	  atmosphere	  with	  5%	  CO2	  [65].	  Cells	  were	  then	  seeded	  onto	  0.4-­‐µm	  pore	  size	  Snapwells	  (Corning)	  and	  grown	  until	  they	  formed	  a	  confluent	  monolayer,	  as	  previously	  described[65,89].	  Once	  confluent,	  the	  apical	  media	  was	  removed	  and	  cells	  continued	  to	  grow	  in	  an	  air-­‐liquid	  interface	  for	  approximately	  one	  week	  prior	  to	  treatment.	  
2.2.	  Viral	  culture	  and	  infection	  
	   Polarized	  Calu3	  cells	  were	  infected	  apically	  with	  A/PR/8/34	  H1N1	  at	  varying	  multiplicity	  of	  infection	  (MOI).	  Influenza	  A	  virus	  was	  propagated	  at	  a	  MOI	  of	  0.001	  in	  Madin-­‐Darby	  canine	  kidney	  (MDCK)	  cells	  and	  purified	  by	  ultracentrifugation	  through	  a	  sucrose	  gradient.	  Stock	  virus	  concentration	  was	  determined	  using	  a	  plaque	  assay	  (see	  section	  2.3.1.)	  and	  quantified	  in	  terms	  of	  plaque-­‐forming	  units	  (PFU)	  per	  cell.	  The	  virus	  was	  diluted	  in	  DMEM	  and	  0.5	  mL	  of	  the	  inoculum	  was	  added	  to	  the	  apical	  surface	  of	  the	  cells	  at	  a	  MOI	  of	  10,	  1,	  0.6,	  or	  0.3.	  Cells	  were	  infected	  apically	  for	  1	  hour,	  after	  which	  they	  were	  washed	  with	  phosphate	  buffered	  saline	  (PBS;	  137mM	  NaCl,	  2.6mM	  KCl,	  1.5mM	  KH2PO4,	  8.1mM	  Na2HPO4)	  to	  remove	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non-­‐adherent	  virus,	  and	  fresh	  DMEM	  was	  replaced	  on	  the	  apical	  surface.	  Similarly,	  the	  control	  cells	  were	  mock	  infected	  using	  DMEM	  only.	  Treated	  cells	  were	  left	  for	  24	  or	  48	  hours	  before	  performing	  any	  downstream	  experiments.	  	  
2.3.	  Conditioned	  media	  	  
	   Four	  types	  of	  conditioned	  media	  were	  generated	  from	  non-­‐polarized,	  confluent	  Calu3	  monolayers	  in	  6-­‐well	  plates	  (Corning):	  FBS-­‐free	  control	  conditioned	  media	  (FBS-­‐free	  CCM),	  FBS-­‐free	  virus-­‐treated	  conditioned	  media	  (FBS-­‐free	  VCM),	  control	  conditioned	  media	  with	  FBS	  (FBS+	  CCM),	  and	  virus-­‐treated	  conditioned	  media	  with	  FBS	  (FBS+	  VCM).	  The	  VCM	  was	  generated	  using	  an	  MOI	  of	  10.	  Cells	  were	  rinsed	  with	  PBS	  after	  one	  hour	  of	  infection,	  and	  3	  mL	  of	  fresh	  media	  (FBS-­‐free	  or	  FBS+)	  was	  replaced	  into	  each	  well.	  After	  48	  hours,	  the	  media	  was	  transferred	  to	  a	  sterile	  6-­‐well	  plate	  30	  cm	  from	  an	  UV	  light	  for	  30	  minutes[122].	  A	  plaque	  assay	  was	  used	  to	  confirm	  that	  the	  virus	  particles	  had	  been	  completely	  inactivated[123].	  	  
2.3.1.	  Plaque	  assay	  
	   Using	  6-­‐well	  plates,	  MDCK	  cells	  were	  seeded	  at	  6	  x	  105	  cells/well	  16-­‐18	  hours	  prior	  to	  assay.	  	  MDCK	  cells	  were	  cultured	  in	  Modified	  Eagle’s	  Medium	  (MEM,	  HyClone)	  supplemented	  with	  10%	  FBS,	  1%	  Penicillin-­‐Streptomycin	  and	  1%	  L-­‐glutamine.	  Serial	  dilutions	  of	  the	  UV-­‐treated	  conditioned	  media	  were	  prepared	  along	  with	  a	  positive	  and	  negative	  control.	  Media	  was	  removed	  from	  MDCK	  cells,	  and	  each	  well	  was	  rinsed	  with	  PBS.	  400	  µL	  of	  each	  sample	  dilution	  were	  added	  to	  the	  wells	  in	  duplicate	  and	  the	  plate	  was	  incubated	  at	  37°C	  for	  1	  hour.	  The	  inoculum	  was	  then	  removed	  from	  each	  well,	  rinsed	  with	  PBS,	  and	  replaced	  with	  3	  mL	  of	  media	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overlay.	  The	  media	  overlay	  contains	  20	  mL	  2X	  MEM	  (supplemented	  with	  2%	  penicillin-­‐streptomycin,	  2%	  L-­‐glutamine),	  1.6	  mL	  5%	  bovine	  serum	  albumin	  (BSA),	  40	  µL	  TPCK	  trypsin	  (1	  mg/mL;	  20233,	  Thermo	  Scientific),	  and	  20	  mL	  1.8%	  agarose.	  The	  overlay	  was	  allowed	  to	  solidify	  for	  10-­‐15	  minutes	  before	  being	  placed	  back	  in	  the	  incubator	  at	  37°C.	  After	  72	  hours,	  the	  agarose-­‐media	  overlay	  was	  carefully	  removed,	  and	  the	  cells	  were	  stained	  with	  2	  mL	  Coomassie	  blue	  (50%	  CH4O,	  10%	  C2H4O2,	  40%	  H2O,	  0.25%	  Coomassie	  Brilliant	  Blue	  R).	  	  
2.4.	  Quantification	  of	  cytokines	  
	   Cytokine	  levels	  in	  the	  conditioned	  media	  were	  quantified	  using	  the	  Bio-­‐Plex	  Pro	  assay	  according	  to	  the	  manufacturer’s	  instructions	  (Bio-­‐Rad)[4].	  Included	  in	  the	  assay	  was	  IL-­‐4,	  IL-­‐6,	  IL-­‐8,	  IL-­‐10,	  TNF-­‐α	  and	  IFN-­‐γ.	  	  
2.4.1.	  Cytokine	  dose	  response	  
	   Interleukin-­‐8	  (IL-­‐8;	  Sigma;	  SRP3098)	  was	  reconstituted	  in	  water	  and	  used	  to	  dose	  polarized	  Calu3	  cells	  for	  48	  hours.	  Cells	  were	  dosed	  apically	  (DMEM)	  and	  basolaterally	  (culture	  media)	  at	  either	  10,	  100,	  or	  1000	  ng/ml	  of	  IL-­‐8[108].	  The	  IL-­‐8	  containing	  media	  was	  changed	  after	  24	  hours	  and	  cells	  were	  left	  for	  a	  total	  of	  48	  hours.	  Downstream	  experiments	  involved	  measurement	  of	  transepithelial	  ion	  transport	  in	  an	  Ussing	  chamber,	  and	  subsequent	  RNA	  extraction	  for	  RT-­‐qPCR.	  	  
2.5.	  Measurement	  of	  transepithelial	  short-­‐circuit	  current	  (Isc)	  	  	  
	   Polarized	  cells	  on	  Snapwells	  were	  mounted	  in	  Ussing	  chambers	  (Physiologic	  Instruments,	  San	  Diego,	  CA)	  (Figure	  8).	  The	  apical	  and	  basolateral	  chambers	  were	  filled	  with	  5	  mL	  Kreb’s	  solution	  containing	  (in	  mM):	  113	  NaCl,	  5	  KCl,	  1.6	  Na2HPO4,	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0.3	  NaH2PO4•H2O,	  25	  NaHCO3,	  1.1	  MgCl2•6H2O,	  2.2	  CaCl2•2H2O,	  and	  10	  glucose[124].	  Chambers	  were	  maintained	  at	  37°C	  and	  bubbled	  with	  5%	  CO2-­‐95%	  O2.	  Transepithelial	  potential	  differences	  were	  short-­‐circuited	  to	  0	  mV	  with	  a	  voltage	  clamp	  on	  the	  apical	  and	  basolateral	  chambers	  using	  Ag-­‐AgCl	  electrodes	  and	  3M	  KCl	  agar	  bridges[108].	  Cells	  were	  clamped,	  and	  allowed	  to	  equilibrate	  for	  a	  minimum	  of	  20	  minutes	  prior	  to	  any	  addition	  of	  drugs	  (see	  table	  1).	  Each	  drug	  was	  added	  at	  6-­‐8	  minute	  intervals.	  Tissue	  was	  pulsed	  every	  30	  seconds	  with	  a	  1	  mV	  pulse	  and	  the	  resulting	  current	  was	  used	  to	  determine	  membrane	  resistance.	  Positive	  current	  deflection	  is	  the	  result	  of	  either	  an	  anion	  moving	  apically,	  or	  a	  cation	  moving	  basolaterally.	  	  
2.5.1.	  Chemicals	  	   All	  chemicals	  and	  drugs	  were	  obtained	  from	  Sigma,	  unless	  otherwise	  noted.	  Forskolin	  (10	  µM;	  F6886)	  and	  3-­‐isobutyl-­‐1-­‐methylxanthine	  (IBMX,	  1	  mM;	  I5879).	  Calcium	  ionophore	  A23187	  (500	  nM;	  C7522).	  Glibenclamide	  (100	  µM;	  G0639).	  Niflumic	  Acid	  (100	  µM;	  N0630).	  TRAM-­‐34	  (20	  µM;	  T6700),	  Chromanol	  293B	  (30	  
µM;	  C2615),	  and	  ICA-­‐17043	  (100	  µM;	  kindly	  provided	  by	  Dr.	  Heike	  Wulff	  from	  the	  University	  of	  California).	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Figure	  8.	  Ussing	  chamber	  model.	  
This	  tool	  allows	  for	  the	  measurement	  of	  short-­‐circuit	  current	  (Isc),	  which	  indicates	  the	  net	  ion	  transport	  occurring	  across	  a	  polarized	  epithelium.	  Cells	  mounted	  in	  the	  chamber	  separate	  the	  apical	  and	  basolateral	  sides,	  which	  are	  bathed	  in	  symmetrical	  solution	  (e.g.,	  Kreb’s	  solution),	  thereby	  eliminating	  any	  electrochemical	  gradient.	  Two	  voltage	  electrodes	  (Ve)	  measure	  the	  potential	  difference,	  which	  is	  cancelled	  out	  by	  the	  imposed	  current	  from	  the	  current	  electrodes	  (Ie).	  This	  current	  is	  referred	  to	  as	  short-­‐circuit	  current,	  and	  represents	  the	  net	  movement	  of	  ions	  across	  the	  epithelium.	  The	  use	  of	  channel	  agonists	  and	  blockers	  will	  alter	  the	  membrane	  resistance	  by	  opening	  or	  closing	  ion	  channels,	  which	  results	  in	  measurable	  changes	  in	  Isc.	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Table	  1.	  Drug	  names	  and	  actions	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2.6.	  RNA	  isolation	  and	  Real-­‐Time	  Quantitative	  PCR	  (RT-­‐qPCR)	  
	   RNA	  was	  extracted	  using	  TRIzol	  Reagent	  (15596018;	  Life	  Technologies)	  according	  to	  the	  manufacturers	  protocol.	  cDNA	  was	  transcribed	  using	  GoScript	  Reverse	  Transcription	  system	  (A5001;	  Promega).	  cDNA	  concentrations	  of	  approximately	  100-­‐150	  ng	  were	  measured	  by	  real-­‐time	  quantitative	  PCR	  using	  GoTaq	  qPCR	  Master	  Mix	  (A6002;	  Promega),	  with	  Stratagene	  MX5000P	  real-­‐time	  PCR	  machines.	  See	  table	  2	  for	  list	  of	  primers.	  
2.6.1.	  Efficiency	  and	  fold	  difference	  calculation	  	  
	   Dilution	  series	  from	  1	  x	  100	  fold	  –	  1	  x	  10-­‐6	  fold	  of	  cDNA	  were	  used	  to	  determine	  the	  primer	  efficiency.	  	  The	  CT	  value	  obtained	  in	  each	  dilution	  was	  used	  to	  generate	  a	  linear	  plot	  of	  CT	  vs.	  log	  copies	  graph.	  	  The	  efficiency	  of	  the	  primer	  set	  is	  determined	  with	  the	  equation:	  Efficiency	  (%)	  =	  10(-­‐1/slope)	  	   The	  fold	  difference	  between	  infected/treated	  and	  non-­‐infected	  cells	  was	  determined	  using	  efficiency	  corrected	  calculation	  model:	  Ratio	  =	  (Efftarget)	  ΔCT	  target	  (	  Mean	  control	  –	  Mean	  sample)	  	   	  	  	  (Effref)	  ΔCT	  ref	  	  (	  Mean	  control	  –	  Mean	  sample)	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Table	  2.	  Primer	  sequences	  used	  for	  RT-­qPCR.	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2.7.	  Western	  blot	  analysis	  	   Protein	  was	  extracted	  from	  Calu3	  cells	  using	  the	  NE-­‐PER	  Nuclear	  and	  Cytoplasmic	  Extraction	  Reagents	  (78833;	  Pierce)	  and	  analyzed	  the	  same	  day.	  Individual	  concentrations	  were	  determined	  using	  Bradford	  Assay	  (Bio-­‐Rad)[125].	  The	  samples	  were	  boiled	  in	  2x	  denaturing	  buffer	  (20%	  glycerol,	  4%	  SDS,	  125mM	  Tris	  pH	  6.8,	  0.3mM	  bromophenol	  blue)	  and	  analyzed	  by	  10%	  SDS-­‐PAGE.	  	  After	  SDS-­‐PAGE,	  proteins	  were	  electroblotted	  onto	  PVDF	  membrane	  (RPN303LFP;	  GE	  Healthcare	  Life	  Sciences)	  with	  transfer	  buffer	  (25mM	  Tris,	  192mM	  glycine,	  20%	  methanol)[94].	  	  Membranes	  were	  blocked	  overnight	  at	  4°C	  with	  5%	  bovine	  serum	  albumin	  in	  PBST	  buffer	  (137mM	  NaCl,	  2.6mM	  KCl,	  1.5mM	  KH2PO4,	  8.1mM	  Na2HPO4,	  0.1%	  Tween-­‐20;	  Sigma)	  and	  subsequently	  probed	  for	  2h	  at	  room	  temperature	  with	  anti-­‐CFTR	  (1:200;	  sc-­‐10747;	  Santa	  Cruz)[94],	  anti-­‐KCNN4	  (1:200;	  sc-­‐32949;	  Santa	  Cruz),	  anti-­‐KCNQ1	  (1:200;	  sc-­‐20816;	  Santa	  Cruz),	  or	  anti-­‐GAPDH	  (1:500;	  sc-­‐25778;	  Santa	  Cruz)[89].	  Infrared-­‐labeled	  secondary	  antibodies	  were	  used	  to	  visualize	  protein.	  Densitometry	  analyses	  of	  individual	  bands	  were	  compared	  for	  statistical	  analysis.	  	  
2.8.	  Statistical	  analysis	  	   All	  data	  are	  expressed	  as	  mean	  ±	  standard	  error	  of	  the	  mean	  (SEM).	  Change	  in	  Isc	  between	  treated	  and	  control	  cells	  were	  analyzed	  using	  parametric	  t-­‐tests,	  or	  ANOVA,	  as	  appropriate.	  One-­‐sample	  t-­‐tests	  were	  performed	  on	  fold	  differences	  from	  data	  obtained	  using	  RT-­‐qPCR	  with	  the	  mean	  set	  as	  1.	  Significance	  was	  determined	  at	  p	  <	  0.05.	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3.1.	  Abstract	  	   Influenza	  A	  infection	  of	  respiratory	  epithelium	  lining	  the	  airways	  produces	  cytokines	  that	  aid	  in	  fighting	  the	  infection.	  These	  same	  cytokines	  by	  themselves	  have	  been	  shown	  to	  modulate	  ion	  channel	  function.	  Movement	  through	  these	  channels	  creates	  the	  osmotic	  drive	  to	  hydrate	  the	  airways.	  However,	  the	  excessive	  increase	  in	  cytokine	  production	  during	  an	  influenza	  infection	  could	  contribute	  to	  excessive	  chloride	  and	  potassium	  channel	  activity	  and	  airway	  over-­‐hydration.	  This	  could	  explain,	  in	  part,	  the	  disruption	  of	  the	  fluid	  balance	  in	  the	  lungs	  and	  the	  resulting	  pulmonary	  edema	  that	  occurs	  during	  severe	  influenza	  infections.	  Using	  RT-­‐qPCR	  we	  measured	  cytokine	  and	  ion	  channel	  expression	  in	  the	  Calu3	  cell	  line	  after	  48-­‐hour	  infection	  with	  influenza	  A	  virus	  (A/PR/8/34	  H1N1).	  We	  simultaneously	  measured	  chloride	  and	  potassium	  channel	  function	  by	  means	  of	  a	  short-­‐circuit	  current	  (Isc)	  produced	  by	  a	  Calu3	  cell	  monolayer	  in	  an	  Ussing	  chamber.	  At	  an	  MOI	  of	  10,	  viral	  M1	  protein	  and	  pro-­‐inflammatory	  cytokine	  expression	  was	  observed	  24	  hours	  post-­‐infection,	  despite	  a	  lack	  of	  measurable	  change	  in	  Isc.	  However,	  we	  observed	  a	  decreased	  secretory	  response	  in	  cAMP-­‐	  and	  calcium-­‐induced	  Isc	  48	  hours	  post-­‐infection.	  This	  was	  a	  result	  of	  a	  virus-­‐induced	  decrease	  in	  CFTR	  and	  KCNN4	  protein.	  	  Interestingly,	  a	  viral	  dose	  response	  revealed	  an	  increased	  secretory	  response	  at	  an	  MOI	  of	  0.6	  (p	  =	  0.015).	  	  This	  response	  correlated	  strongly	  with	  increased	  pro-­‐inflammatory	  cytokine	  expression,	  suggesting	  a	  paracrine	  regulation	  of	  non-­‐infected	  cells.	  This	  secretory	  response	  seems	  to	  be	  primarily	  driven	  through	  KCNN4,	  as	  up-­‐regulation	  of	  both	  mRNA	  (p	  =	  0.005)	  and	  protein	  (p	  <	  0.001)	  levels	  were	  detected	  while	  CFTR	  function	  and	  expression	  remained	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unchanged.	  Furthermore,	  inhibition	  of	  the	  KCNN4-­‐stimulated	  Isc	  with	  TRAM-­‐34,	  a	  specific	  inhibitor,	  ameliorated	  the	  response,	  implicating	  KCNN4	  as	  the	  main	  driving	  force	  behind	  the	  secretory	  phenotype.	  	  	  
3.2.	  Introduction	  	   Seasonal	  circulating	  strains	  of	  influenza	  A	  virus	  infect	  millions	  of	  individuals	  worldwide[8].	  These	  infections	  result	  in	  over	  half-­‐a-­‐million	  deaths	  annually,	  with	  mortality	  rates	  substantially	  higher	  when	  novel	  pandemic	  strains	  emerge[126].	  The	  deaths	  are	  primarily	  due	  to	  influenza’s	  ability	  to	  infect	  and	  disrupt	  the	  basic	  cellular	  mechanisms	  of	  ciliated	  epithelial	  cells	  lining	  the	  upper	  respiratory	  tract[127,128,129].	  These	  cells	  are	  normally	  responsible	  for	  regulating	  the	  airway	  surface	  liquid	  (ASL),	  a	  thin	  film	  of	  fluid	  that	  covers	  the	  airways[11,130].	  The	  ASL,	  maintained	  at	  appropriate	  volumes,	  allows	  the	  cilia	  of	  the	  epithelium	  to	  beat,	  clearing	  the	  lungs	  of	  mucus	  and	  inhaled	  contaminants	  (referred	  to	  as	  mucociliary	  clearance)[10,18,19].	  The	  cells	  maintain	  the	  ASL	  by	  establishing	  an	  osmotic	  gradient	  across	  the	  epithelium[11,39].	  This	  process	  is	  driven	  by	  the	  transport	  of	  sodium,	  chloride	  and	  potassium	  through	  ion	  channels	  and	  pumps[11,12].	  Simply,	  potassium	  exits	  through	  ion	  channels	  on	  the	  apical	  and	  basolateral	  sides	  of	  the	  polarized	  epithelium,	  increasing	  the	  negative	  charge	  within	  the	  cell[11,89,91].	  This,	  in	  turn,	  drives	  chloride	  into	  the	  airways	  through	  ion	  channels	  on	  the	  apical	  side,	  generating	  the	  gradient	  for	  both	  sodium	  and	  water	  to	  follow[11,28].	  Chloride	  exits	  the	  apical	  membrane	  either	  through	  the	  cAMP-­‐activated	  cystic	  fibrosis	  transmembrane	  regulator	  (CFTR)	  channel,	  or	  calcium-­‐activated	  chloride	  channels	  (CaCC)[11].	  The	  importance	  of	  CFTR	  is	  illustrated	  by	  its	  mutational	  loss	  in	  the	  disease	  of	  cystic	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fibrosis	  (CF).	  In	  CF,	  the	  lack	  of	  CFTR	  results	  in	  under-­‐hydration	  of	  the	  airways	  leading	  to	  decreased	  ASL	  levels	  and	  impairment	  of	  mucociliary	  clearance	  [37,97,131].	  Alternatively,	  increased	  movement	  of	  chloride	  through	  CFTR,	  or	  CaCC,	  results	  in	  over-­‐hydration	  of	  the	  airways,	  which	  can	  lead	  to	  pulmonary	  edema[33,40].	  If	  not	  corrected,	  this	  edema	  formation	  can	  ultimately	  drown	  the	  patient[33].	  	  Such	  severe	  pulmonary	  edema	  is	  particularly	  salient	  in	  patients	  suffering	  from	  acute,	  complicated	  influenza	  infections[11,40,61].	  	  	   The	  exact	  mechanism	  by	  which	  influenza	  A	  virus	  infection	  can	  cause	  the	  formation	  of	  pulmonary	  edema	  remains	  unclear	  [23].	  Initial	  studies	  have	  identified	  that	  the	  interaction	  of	  the	  virus	  with	  the	  epithelium	  leads	  to	  a	  reduced	  ability	  to	  clear	  fluid	  from	  the	  airways	  [60,61,62,76].	  These	  studies	  specifically	  emphasize	  how	  down-­‐regulation	  of	  the	  epithelial	  sodium	  channel	  (ENaC)	  impacts	  fluid	  clearance,	  as	  a	  direct	  result	  of	  viral	  attachment	  [60,62,76].	  Since	  ENaC	  is	  responsible	  for	  absorbing	  sodium	  from	  the	  airways,	  this	  down-­‐regulation	  reduces	  the	  net	  movement	  of	  water	  from	  the	  apical	  side[12].	  This	  can	  ultimately	  lead	  to	  the	  formation	  of	  pulmonary	  edema	  in	  acute	  influenza	  infections[60,61,76].	  	  	   However,	  the	  formation	  of	  pulmonary	  edema	  could	  also	  result	  from	  increased	  secretion,	  rather	  than	  decreased	  absorption	  (fluid	  clearance).	  This	  may	  be	  true	  in	  a	  natural	  infection	  where	  a	  large	  percentage	  of	  the	  cells	  are	  not	  infected	  and,	  instead,	  subject	  to	  paracrine	  regulation	  by	  infected	  cells[132,133].	  Upon	  infection,	  epithelial	  cells	  respond	  by	  releasing	  a	  variety	  of	  inflammatory	  mediators[50,129].	  These	  mediators	  are	  cytokines	  that	  aid	  in	  fighting	  the	  infection,	  and	  some,	  such	  as	  TNF-­‐α,	  IL-­‐1β,	  and	  IFN-­‐γ,	  have	  been	  shown	  to	  independently	  increase	  net	  anion	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secretion[48,58,107].	  This	  results	  in	  increased	  airway	  fluid	  volume	  and	  is	  driven	  primarily	  through	  cytokines	  acting	  on	  non-­‐infected	  cells[48,58,134].	  Such	  an	  effect	  would	  most	  likely	  be	  mediated	  through	  increased	  CFTR	  activity	  on	  the	  apical	  membrane	  or	  increased	  potassium	  movement	  through	  the	  major	  epithelial	  potassium	  channels	  KCNN4	  or	  KCNQ1[11,89].	  	  	   To	  investigate	  the	  presence	  of	  a	  secretory	  airway	  response	  to	  influenza	  A	  virus	  infection,	  we	  used	  the	  well-­‐established	  secretory	  airway	  epithelial	  serous	  cell	  model,	  Calu3[63,86].	  The	  underlying	  drive	  for	  chloride	  secretion	  in	  this	  cell	  line	  comes	  from	  a	  small	  apical	  CaCC,	  highly	  abundant	  CFTR,	  as	  well	  as	  the	  potassium	  channels	  KCNN4	  and	  KCNQ1[24,63,65,86,135].	  Using	  this	  cell	  line	  we	  determined	  the	  effect	  of	  an	  influenza	  virus	  dose	  response	  on	  chloride	  and	  potassium	  channel	  expression	  and	  function	  as	  measured	  by	  Ussing	  chamber	  Isc.	  Initially,	  we	  sought	  to	  characterize	  the	  effects	  of	  influenza	  virus	  infection	  on	  polarized	  Calu3	  cell	  monolayers	  and	  assess	  the	  innate	  immune	  response	  elicited	  by	  our	  cell	  model.	  Our	  goal	  was	  to	  model	  the	  in	  vivo	  situation	  where	  only	  a	  small	  percentage	  of	  the	  airway	  cells	  are	  infected,	  leaving	  the	  non-­‐infected	  cells	  available	  for	  paracrine	  regulation	  by	  virus-­‐induced	  mediators,	  such	  as	  pro-­‐inflammatory	  cytokines.	  
3.3.	  Materials	  and	  Methods	  
Refer	  to	  chapter	  2	  	  
3.4.	  Results	  and	  discussion	  	   To	  determine	  the	  effect	  of	  influenza	  A	  infection	  and	  replication	  on	  transepithelial	  ion	  transport,	  as	  a	  measurement	  of	  epithelial	  secretion	  we	  infected	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polarized	  Calu3	  cell	  monolayers	  with	  influenza	  virus	  (H1N1)	  at	  an	  MOI	  of	  10	  (i.e.,	  10	  virus	  particles	  per	  cell).	  The	  initial	  use	  of	  a	  high	  MOI	  (Figures	  9	  and	  10)	  was	  used	  for	  several	  reasons.	  This	  ensured	  that	  all	  cells	  were	  infected,	  and	  allowed	  us	  to	  characterize	  the	  immune	  response.	  Influenza-­‐related	  fatalities	  resulting	  from	  pulmonary	  edema	  are	  often	  associated	  with	  higher	  viral	  loads	  and	  a	  strong	  inflammatory	  response	  [133,136].	  Additionally,	  this	  initial	  high	  viral	  dose	  circumvented	  any	  problems	  associated	  with	  pandemic	  H1N1	  eliciting	  an	  attenuated	  immune	  response,	  as	  this	  phenomenon	  has	  been	  previously	  reported[4,66].	  	   Unexpectedly,	  24	  hours	  after	  infection	  despite	  the	  beginnings	  of	  a	  strong	  immune	  response	  and	  viral	  replication,	  as	  determined	  by	  cytokine	  transcript	  accumulation	  (Figure	  9E)	  and	  M1	  viral	  protein	  production	  (Figure	  9F,G),	  there	  was	  no	  statistical	  change	  in	  epithelial	  resistance,	  a	  measure	  of	  tight	  junction	  permeability.	  Infected	  cells	  had	  a	  resistance	  of	  90.8	  ±	  8.34	  Ωcm2	  whereas	  non-­‐infected	  cells	  had	  a	  resistance	  of	  105.3	  ±	  8.51	  Ωcm2.	  	  Additionally,	  we	  observed	  no	  difference	  in	  cAMP-­‐	  or	  calcium-­‐induced	  Isc,	  a	  measurement	  of	  epithelial	  secretion,	  between	  infected	  and	  non-­‐infected	  epithelium	  (Figures	  9A-­‐D).	  We	  had	  expected	  to	  detect	  a	  change	  in	  Isc	  after	  24	  hours	  of	  infection	  at	  an	  MOI	  of	  10,	  as	  previous	  studies	  had	  found	  an	  impact	  on	  sodium	  absorption	  within	  a	  few	  hours[60].	  These	  studies	  only	  assessed	  the	  direct	  impact	  of	  influenza	  virus	  during	  the	  early	  stage	  processes	  of	  viral	  attachment,	  and	  endocytosis,	  occurring	  within	  a	  1-­‐hour	  period[60,61].	  These	  early	  time	  point	  events	  do	  not	  take	  into	  account	  the	  dynamic	  virus-­‐host	  interactions	  that	  occur	  upon	  initiation	  of	  viral	  replication,	  as	  the	  average	  incubation	  period	  for	  influenza	  is	  24-­‐48	  hours[8].	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Figure	  9.	  Effect	  of	  a	  high	  viral	  dose	  of	  influenza	  (MOI	  10)	  on	  Calu3	  cells	  24	  
hours	  post-­infection.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  control	  and	  virus-­‐infected	  cells.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  among	  control	  (C)	  and	  virus-­‐infected	  (D)	  cells.	  	  Change	  in	  cytokine	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  (E).	  	  Western	  blot	  and	  densitometry	  analysis	  of	  influenza	  virus	  M1	  protein	  (~	  31	  kDa)	  compared	  to	  GAPDH	  (~37	  kDa)	  reference	  (F).	  Isc	  =	  short-­‐circuit	  current;	  UD	  =	  undetectable;	  Data	  presented	  as	  mean	  ±	  SEM,	  and	  analyzed	  using	  t-­‐test.	  *	  =	  p	  <	  0.05	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Furthermore,	  viral	  shedding	  and	  the	  induction	  of	  apoptosis	  occur	  as	  late	  as	  4	  days	  post-­‐infection[8].	  Thus,	  we	  had	  predicted	  that	  24	  hours	  post-­‐infection	  would	  reveal	  a	  difference	  in	  ion	  channel	  physiology,	  in	  addition	  to	  increased	  cytokine	  levels.	  However,	  we	  only	  detected	  significant	  increases	  in	  mRNA	  of	  IL-­‐6,	  IL-­‐8,	  IL-­‐1α	  and	  IL-­‐1β	  (Figure	  9E)	  and	  no	  change	  ion	  channel	  function.	  We	  concluded	  since	  all	  cells	  were	  infected	  that,	  in	  our	  cell	  model,	  more	  time	  was	  required	  in	  order	  to	  observe	  a	  measurable	  difference	  in	  ion	  channel	  transport.	  Therefore,	  we	  proceeded	  to	  assess	  the	  impact	  of	  virus	  infection	  on	  cells	  at	  48	  hours	  post-­‐infection.	  	  	   Interestingly,	  after	  48	  hours	  at	  an	  MOI	  of	  10	  we	  observed	  a	  decreased	  secretory	  response,	  as	  indicated	  from	  a	  significant	  decrease	  in	  the	  cAMP-­‐	  and	  calcium-­‐activated	  Isc	  of	  the	  infected	  cells	  (Figure	  10A).	  Also,	  there	  was	  decreased	  chloride	  conductance	  after	  inhibition	  with	  glibenclamide,	  but	  not	  niflumic	  acid	  (Figure	  10B).	  Moreover,	  the	  epithelial	  resistance	  of	  infected	  cells	  was	  significantly	  decreased	  compared	  to	  controls	  (61.5	  ±	  7.02	  Ωcm2	  and	  145.1	  ±	  21.2	  Ωcm2,	  respectively;	  p	  =	  0.002).	  It	  is	  known	  that	  prolonged	  exposure	  to	  influenza	  virus	  leads	  to	  apoptosis	  [23,35,133];	  therefore,	  the	  significant	  decrease	  in	  epithelial	  resistance,	  especially	  at	  this	  high	  dose,	  was	  not	  surprising.	  Despite	  detecting	  a	  decreased	  secretory	  response	  the	  reduction	  in	  epithelial	  resistance	  would	  compromise	  the	  epithelial	  barrier.	  	  The	  weakening	  of	  the	  epithelium	  would	  lead	  to	  the	  development	  of	  pulmonary	  edema	  because	  hydrostatic	  pressure	  would	  force	  fluid	  into	  the	  airway	  [39].	  Chen	  et	  al.	  discuss	  that	  part	  of	  the	  pathogenesis	  of	  influenza	  is	  a	  result	  of	  an	  increased	  viral	  load	  damaging	  the	  epithelial	  barrier	  such	  that	  the	  patient	  is	  unable	  to	  recover	  from	  the	  massive	  flooding	  of	  fluid	  [62].	  	  This	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exacerbates	  the	  direct	  effects	  influenza	  has	  on	  ion	  transport	  in	  a	  functioning	  epithelium,	  which	  has	  been	  shown	  to	  also	  lead	  to	  pulmonary	  edema[60].	  	   Interestingly,	  this	  decreased	  secretory	  response	  was	  not	  due	  to	  a	  decrease	  in	  transcription	  of	  the	  transporters	  responsible	  for	  driving	  secretion.	  	  RT-­‐qPCR	  analysis	  of	  mRNA	  levels	  for	  CFTR,	  KCNN4,	  or	  the	  basolateral	  Na+-­‐K+-­‐2Cl-­‐	  co-­‐transporter	  (NKCC1)	  and	  Na+-­‐K+-­‐ATPase	  (ATP1A1)	  were	  unchanged	  (Figure	  10E).	  Further	  investigation	  using	  western	  blotting	  indicates	  that	  both	  CFTR	  and	  KCNN4	  protein	  levels	  are	  significantly	  decreased	  in	  the	  infected	  cells	  (p	  =	  0.002;	  p	  =	  0.022;	  Figure	  10F,	  G).	  Given	  that	  mRNA	  levels	  remained	  unchanged,	  it	  appears	  that	  at	  a	  high	  viral	  dose,	  there	  is	  post-­‐transcriptional	  modification	  of	  both	  the	  CFTR	  and	  KCNN4	  ion	  channels,	  resulting	  in	  an	  overall	  decrease	  in	  transepithelial	  Isc.	  A	  possible	  explanation	  for	  this	  phenomenon	  is	  during	  influenza	  virus	  replication	  the	  viral	  polymerase	  subunit,	  PA,	  utilizes	  a	  cap-­‐snatching	  mechanism	  in	  order	  to	  transcribe	  the	  viral	  genome—a	  process	  involving	  removal	  of	  host	  5’	  mRNA	  caps[137].	  These	  uncapped	  host	  mRNAs	  are	  then	  targeted	  for	  degradation,	  as	  they	  cannot	  be	  translated	  without	  a	  5’	  cap.	  Despite	  the	  fact	  that	  there	  have	  not	  been	  any	  reports	  regarding	  the	  specificity	  of	  the	  viral	  polymerase	  to	  any	  host	  genes,	  the	  process	  may	  partially	  explain	  the	  reduced	  ion	  channel	  protein	  expression.	  Since	  we	  detected	  no	  change	  in	  ion	  channel	  mRNA,	  it	  is	  possible	  that	  the	  mRNA	  expression	  in	  the	  infected	  cells	  is	  being	  up-­‐regulated,	  but	  with	  the	  intense	  viral	  replication	  any	  up-­‐regulation	  of	  mRNA	  may	  be	  masked,	  which	  is	  why	  we	  only	  detected	  significant	  changes	  in	  protein	  expression.	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Figure	  10.	  Effect	  of	  a	  high	  viral	  dose	  of	  influenza	  (MOI	  10)	  on	  Calu3	  cells	  48	  
hours	  post-­infection.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  control	  and	  virus-­‐infected	  cells.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  among	  control	  and	  virus-­‐infected	  cells	  (C).	  	  Change	  in	  cytokine	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  (D).	  	  Change	  in	  ion	  channel	  and	  ion	  transporter	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  (E).	  	  Western	  blot	  (F)	  and	  densitometry	  	  (G)	  of	  CFTR	  (~150	  kDa),	  KCNN4	  (~45	  kDa),	  and	  influenza	  M1	  protein	  (~31	  kDa)	  compared	  to	  GAPDH	  (~37	  kDa)	  reference.	  	  Isc	  =	  short-­‐circuit	  current;	  CFTR	  =	  cystic	  fibrosis	  transmembrane	  regulator;	  NKCC1	  =	  Na+-­‐K+-­‐2Cl-­‐	  cotransporter;	  ATP1A1	  =	  Na+-­‐K+	  ATPase;	  UD	  =	  undetectable;	  Data	  presented	  as	  mean	  ±	  SEM,	  analyzed	  using	  t-­‐test.	  *	  =	  p	  <	  0.05	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   Additionally,	  we	  detected	  a	  significant	  increase	  in	  IL-­‐6,	  IL-­‐8,	  IL-­‐1α,	  IL-­‐1β,	  IL-­‐12α	  and	  TNF-­‐α	  cytokine	  mRNA	  (Figure	  10D),	  indicating	  that	  the	  virus	  is	  capable	  of	  eliciting	  a	  strong	  immune	  response	  in	  our	  cell	  model.	  Up-­‐regulation	  of	  these,	  and	  other	  inflammatory	  cytokines,	  is	  required	  to	  fight	  the	  viral	  infection[46].	  However,	  the	  intense	  production	  of	  cytokines	  contributes	  to	  the	  pathogenesis	  by	  exacerbating	  the	  inflammatory	  response,	  which	  often	  correlates	  with	  increased	  fluid	  secretion	  in	  the	  airways[46,48,61,138].	  This	  phenomenon	  may	  be	  a	  result	  of	  both	  the	  virus,	  and	  subsequent	  stimulation	  of	  the	  immune	  response,	  inducing	  changes	  in	  ion	  channel	  expression	  [48,60,61,117].	  Both	  TNF-­‐α	  and	  IL-­‐1β	  have	  been	  directly	  implicated	  in	  impairing	  fluid	  clearance	  in	  the	  airways[48,59,117].	  It	  is	  evident	  that	  after	  48	  hours,	  at	  a	  high	  MOI,	  there	  is	  a	  strong	  up-­‐regulation	  of	  pro-­‐inflammatory	  mediators	  (Figure	  10D).	  Additionally,	  it	  should	  be	  noted	  that	  in	  a	  natural	  in	  vivo	  infection,	  not	  all	  of	  the	  cells	  in	  the	  airway	  would	  become	  infected[132].	  This	  is	  important,	  as	  discussed	  by	  Oh	  et	  al.	  [133],	  in	  the	  context	  of	  apoptosis,	  as	  lower	  doses	  of	  virus	  result	  in	  more	  non-­‐infected	  cells	  that	  can	  then	  be	  regulated	  by	  infected	  cells	  in	  a	  paracrine	  fashion.	  	  This	  paracrine	  cytokine	  regulation	  has	  implications	  in	  the	  development	  of	  pulmonary	  edema	  [48,59,117].	  Therefore,	  we	  investigated	  the	  impact	  of	  a	  lower	  dose	  of	  virus	  in	  our	  epithelial	  cell	  model,	  using	  an	  MOI	  of	  1,	  or	  less,	  to	  determine	  whether	  a	  particular	  dose	  would	  elicit	  an	  immune	  response	  that	  would,	  in	  turn,	  increase	  secretion.	  	   Interestingly,	  when	  the	  epithelium	  was	  only	  30%	  infected	  (MOI	  0.3)	  we	  observed	  no	  detectable	  ion	  transport	  or	  epithelial	  resistance	  changes	  48	  hours	  post-­‐infection	  (Figure	  11A,B).	  Additionally,	  this	  low	  infectious	  dose	  correlated	  with	  a	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relatively	  low	  induction	  of	  pro-­‐inflammatory	  cytokine	  mRNA	  (Figure	  11G).	  However,	  increasing	  the	  dose	  to	  an	  MOI	  of	  1,	  again,	  resulted	  in	  a	  decrease	  in	  cAMP-­‐	  and	  calcium-­‐activated	  Isc	  (Figure	  11E).	  Additionally,	  a	  significant	  decrease	  in	  epithelial	  resistance	  of	  infected	  cells	  was	  detected	  (119.1	  ±	  14.3Ωcm2)	  compared	  to	  non-­‐infected	  cells	  (348.2	  ±	  59.3Ωcm2).	  These	  results	  are	  similar	  to	  that	  of	  the	  high	  viral	  dose	  (MOI	  10;	  Figure	  10A),	  which	  would	  lead	  to	  apoptosis	  and	  a	  compromised	  epithelial	  barrier.	  However,	  an	  intermediary	  dose	  (MOI	  0.6)	  where	  60%	  of	  the	  epithelium	  is	  infected,	  a	  significant	  increase	  in	  the	  calcium-­‐activated	  Isc	  was	  detected	  (p	  =	  0.015;	  Figure	  11C).	  Interestingly,	  with	  this	  infectious	  dose	  there	  was	  no	  difference	  in	  epithelial	  resistance	  between	  infected	  (189.7	  ±	  18.1Ωcm2)	  and	  non-­‐infected	  (229.3	  ±	  25.1	  Ωcm2)	  cells.	  An	  MOI	  of	  0.6	  was	  able	  to	  increase	  the	  secretory	  response	  without	  resulting	  in	  an	  increase	  in	  the	  epithelial	  barrier	  permeability.	  	  	   We	  speculated	  that	  the	  low	  MOI	  (0.3)	  was	  not	  sufficient	  to	  cause	  a	  significant	  paracrine	  impact	  on	  ion	  channel	  physiology	  because	  there	  were	  no	  measurable	  differences	  in	  Isc	  between	  infected	  and	  non-­‐infected	  cells.	  The	  response	  of	  the	  cells	  infected	  at	  an	  MOI	  of	  1	  closely	  resembled	  that	  of	  the	  MOI	  of	  10.	  This	  lead	  us	  to	  conclude	  that	  infecting	  at	  an	  MOI	  ≥	  1,	  or	  under	  conditions	  where	  every	  cell	  is	  infected	  with	  virus,	  that	  despite	  any	  chemokine,	  paracrine	  or	  autocrine	  regulation	  there	  will	  be	  a	  decrease	  in	  its	  secretory	  response.	  	  Results	  obtained	  from	  using	  the	  intermediary	  dose	  (MOI	  0.6)	  demonstrates	  that	  when	  the	  entire	  epithelium	  is	  not	  infected,	  as	  would	  occur	  during	  a	  natural	  infection,	  there	  is	  an	  increased	  secretory	  response.	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Figure	  11.	  Viral	  dose	  response	  has	  varying	  effects	  on	  short-­circuit	  current.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A,	  C,	  E)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B,	  D,	  F)	  in	  control	  and	  virus-­‐infected	  cells.	  	  Virus-­‐infected	  cells	  treated	  with	  MOIs	  of	  0.3	  (A,	  B),	  0.6	  (C,	  D),	  and	  1.0	  (E,	  F).	  	  Change	  in	  cytokine	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  for	  MOIs	  0.3,	  0.6	  and	  1	  (G).	  	  Change	  in	  ion	  channel	  and	  ion	  transporter	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  at	  MOI	  0.6	  (H).	  	  Western	  blot	  (I)	  and	  densitometry	  (J)	  of	  CFTR	  (~150	  kDa)	  and	  KCNN4	  (~45	  kDa)	  compared	  to	  GAPDH	  (~37	  kDa)	  reference.	  	  MOI	  =	  multiplicity	  of	  infection;	  Isc	  =	  short-­‐circuit	  current;	  CFTR	  =	  cystic	  fibrosis	  transmembrane	  regulator;	  NKCC1	  =	  Na+-­‐K+-­‐2Cl-­‐	  cotransporter;	  ATP1A1	  =	  Na+-­‐K+	  ATPase.	  Data	  presented	  as	  mean	  ±	  SEM,	  individual	  experiments	  analyzed	  using	  t-­‐test.	  *	  =	  p	  <	  0.05;	  **	  =	  p	  <	  0.001	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This	  resulting	  secretory	  phenotype	  best	  represents	  the	  physiological	  response	  to	  a	  natural	  influenza	  infection.	  	  	   Analysis	  of	  the	  underlying	  mechanism	  driving	  this	  secretory	  response	  revealed	  that	  an	  MOI	  of	  0.6	  correlated	  with	  an	  increase	  in	  KCNN4	  mRNA	  (p	  =	  0.005;	  Figure	  11H)	  and	  protein	  (p	  <	  0.001;	  Figure	  11I,	  J).	  KCNN4,	  a	  calcium-­‐activated	  potassium	  channel,	  plays	  a	  significant	  role	  in	  lowering	  the	  membrane	  potential	  and	  driving	  anion	  secretion	  [65].	  Up-­‐regulation	  of	  this	  channel,	  in	  particular,	  would	  result	  in	  an	  increased	  drive	  for	  apical	  chloride	  secretion	  and	  a	  greater	  movement	  of	  fluid	  into	  the	  airways.	  Additionally,	  up-­‐regulated	  levels	  of	  CFTR	  could	  produce	  the	  same	  results;	  however,	  analysis	  at	  the	  mRNA	  and	  protein	  level	  indicates	  that	  CFTR	  is	  unchanged	  (Figure	  11H,	  I).	  Given	  that	  we	  observed	  a	  virus	  dose-­‐dependent	  up-­‐regulation	  of	  inflammatory	  cytokines	  (Figure	  11G),	  the	  partially	  infected	  epithelium	  (i.e.,	  MOI	  of	  0.6)	  could	  create	  an	  environment	  with	  strong	  paracrine	  regulation	  of	  the	  non-­‐infected,	  healthy	  cells.	  This	  paracrine	  regulation	  could	  be	  driving	  the	  up-­‐regulation	  of	  KCNN4	  at	  an	  MOI	  of	  0.6.	  Such	  a	  mechanism,	  if	  occurring	  in	  vivo,	  would	  ultimately	  contribute	  to	  the	  formation	  of	  pulmonary	  edema	  through	  an	  increased	  driving	  force	  for	  the	  movement	  of	  chloride	  into	  the	  airways.	  	  	  	   We	  confirmed	  the	  functional	  role	  of	  KCNN4	  by	  removing	  its	  potential	  contribution	  to	  Isc	  with	  TRAM-­‐34	  (specific	  inhibitor	  of	  KCNN4)[139].	  Infected	  epithelium	  (MOI	  0.6)	  inhibited	  with	  TRAM-­‐34	  had	  significantly	  reduced	  calcium-­‐activated	  Isc	  compared	  to	  non-­‐infected	  control	  cultures	  (p	  <	  0.001;	  Figure	  12A).	  Given	  that	  KCNN4	  mRNA	  and	  protein	  levels	  were	  significantly	  increased	  over	  controls	  when	  60%	  of	  the	  epithelium	  was	  infected,	  we	  expected	  to	  see	  a	  greater	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degree	  of	  inhibition	  in	  the	  infected	  epithelium.	  More	  specifically,	  inhibition	  of	  the	  KCNN4-­‐associated	  current	  significantly	  decreased	  the	  overall	  Isc	  by	  98%	  in	  infected	  cells,	  and	  91%	  in	  non-­‐infected	  cells	  (Figure	  12A).	  This	  study	  demonstrates	  that	  in	  our	  cell	  model	  when	  60%	  of	  the	  epithelium	  is	  infected,	  the	  driving	  force	  for	  apical	  chloride	  secretion	  is	  increased,	  as	  a	  result	  of	  up-­‐regulated	  levels	  of	  KCNN4.	  This	  channel	  may	  be	  only	  partially	  responsible	  for	  this	  secretory	  response,	  but	  our	  data	  suggest	  that	  KCNN4	  is	  the	  primary	  channel	  responsible	  for	  the	  increased	  calcium-­‐activated	  Isc.	  Infecting	  at	  an	  MOI	  of	  0.6,	  in	  our	  model,	  may	  mirror	  what	  occurs	  in	  vivo	  during	  complicated,	  acute	  influenza	  infection,	  as	  not	  all	  of	  the	  cells	  become	  infected	  and	  there	  is	  potential	  for	  paracrine	  regulation	  of	  these	  non-­‐infected	  cells.	  Development	  of	  pulmonary	  edema	  may	  be	  a	  result	  from	  up-­‐regulation	  of	  KCNN4,	  which	  acts	  to	  increase	  apical	  anion	  secretion.	  	  	   Detection	  of	  a	  secretory	  response	  to	  influenza	  infection	  and	  identification	  of	  the	  key	  ion	  channel	  driving	  the	  response	  may	  open	  a	  new	  area	  of	  pharmacotherapy.	  Our	  study	  is	  the	  first	  to	  identify	  KCNN4	  as	  a	  potential	  target	  for	  drug	  therapy	  to	  reduce	  the	  severity	  of	  influenza	  virus	  infections	  with	  regards	  to	  pulmonary	  edema	  formation.	  Further	  mechanistic	  investigations	  are	  required	  in	  order	  to	  understand	  the	  interaction	  between	  influenza	  and	  KCNN4.	  	  However,	  there	  is	  potential	  for	  use	  of	  clinically	  available	  inhibitors	  to	  improve	  the	  clinical	  outcomes	  in	  patients	  suffering	  from	  severe	  influenza	  infections[139,140].	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Figure	  12.	  TRAM-­34	  inhibition	  reduces	  calcium-­stimulated	  current	  in	  Calu3	  
cell	  monolayers	  infected	  with	  influenza	  virus	  at	  MOI	  0.6	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  control	  and	  virus-­‐infected	  cells	  exposed	  to	  the	  KCNN4	  inhibitor	  TRAM-­‐34	  or	  DMSO	  control.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  among	  control	  cells	  exposed	  to	  DMSO	  control	  (C)	  or	  TRAM-­‐34	  inhibitor	  (D)	  and	  virus-­‐infected	  cells	  exposed	  to	  DMSO	  control	  (E)	  or	  TRAM-­‐34	  inhibitor	  (F).	  Isc	  =	  short-­‐circuit	  current.	  Data	  presented	  as	  mean	  ±	  SEM,	  analyzed	  using	  two-­‐way	  ANOVA	  with	  an	  interaction	  term.	  	  *	  =	  p	  <	  0.05;	  **	  =	  p	  <	  0.001	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CHAPTER	  4.	  RELATIONSHIP	  BETWEEN	  MANUSCRIPTS	  
	  	   The	  first	  objective	  was	  to	  determine	  if	  exposure	  of	  Calu3	  cells	  to	  influenza	  virus	  infection	  for	  24	  and	  48	  hours	  at	  a	  high	  MOI	  would	  modulate	  chloride	  and/or	  potassium	  ion	  channel	  function.	  Our	  findings	  in	  chapter	  3	  at	  24	  hours	  indicate	  that	  even	  at	  a	  high	  viral	  dose	  there	  is	  no	  observed	  change	  in	  ion	  channel	  function.	  However,	  after	  48	  hours	  of	  infection,	  we	  did	  observe	  significant	  decreases	  in	  both	  chloride	  and	  potassium	  ion	  channel	  function.	  This	  finding	  supports	  our	  original	  hypothesis	  that	  a	  high	  dose	  of	  virus	  would	  lead	  to	  a	  decrease	  in	  ion	  channel	  conductance.	  Additionally,	  we	  determined	  that	  using	  a	  high	  dose	  of	  virus	  results	  in	  decreased	  epithelial	  resistance.	  	   Our	  secondary	  objective	  was	  to	  determine	  a	  physiologically	  relevant	  dose	  of	  virus	  that	  would	  be	  capable	  of	  eliciting	  an	  immune	  response	  sufficient	  enough	  to	  modulate	  ion	  channel	  conductance.	  Varying	  the	  viral	  dose	  revealed	  that	  when	  approximately	  60%	  of	  cells	  are	  infected,	  we	  observe	  an	  increase	  in	  secretion.	  This	  result	  is	  likely	  due	  to	  the	  up-­‐regulated	  levels	  of	  pro-­‐inflammatory	  cytokines	  acting	  to	  up-­‐regulate	  the	  potassium	  channel	  KCNN4.	  	  	   In	  order	  to	  complete	  the	  study	  and	  address	  our	  remaining	  objectives,	  we	  subjected	  non-­‐infected	  cells	  to	  a	  mixture	  of	  pro-­‐inflammatory	  cytokines,	  so	  as	  to	  model	  the	  paracrine	  regulation	  independently	  from	  the	  virus.	  Chapter	  5	  addresses	  the	  results	  pertaining	  to	  specific	  objectives	  3	  and	  4.	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CHAPTER	  5.	  H1N1	  DRIVES	  A	  PARACRINE	  REGULATION	  OF	  CALU3	  
CELLS	  THAT	  RESULTS	  IN	  A	  HYPERSECRETORY	  RESPONSE	  AND	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5.1.	  Abstract	  
	   Influenza	  A	  virus	  pathogenesis	  involves	  the	  initial	  infection	  of	  upper	  airway	  epithelium	  and	  subsequent	  induction	  of	  the	  host	  immune	  response.	  Initial	  studies	  indicate	  that	  influenza	  virus	  can	  modulate	  ion	  channel	  function	  resulting	  in	  impairment	  of	  mucociliary	  clearance.	  This	  disruption	  to	  the	  fluid	  balance	  in	  the	  airways	  leads	  to	  pulmonary	  edema	  and	  Acute	  Respiratory	  Distress	  Syndrome	  (ARDS).	  Additionally,	  the	  strong	  inflammatory	  response	  initiated	  by	  viral	  infection	  aids	  in	  fighting	  the	  virus,	  but	  has	  also	  been	  shown	  to	  further	  modulate	  ion	  channel	  transport.	  Here,	  we	  have	  described	  the	  effect	  of	  cytokine-­‐containing	  conditioned	  media	  (CM)	  on	  non-­‐infected,	  polarized	  Calu3	  cell	  monolayers.	  This	  mirrors	  the	  situation	  observed	  during	  influenza	  infections	  where	  the	  majority	  of	  cells	  are	  not	  infected	  with	  the	  virus,	  but	  are	  exposed	  to	  the	  paracrine	  effects	  of	  inflammatory	  cytokine	  mediators	  from	  the	  infected	  cells.	  Treatment	  with	  CM	  resulted	  in	  an	  increased	  secretory	  phenotype	  after	  48	  hours	  (p	  <	  0.001).	  	  The	  chloride	  and	  potassium	  channel	  function	  was	  measured	  by	  means	  of	  a	  short-­‐circuit	  current	  (Isc)	  produced	  by	  the	  Calu3	  cell	  monolayer	  in	  an	  Ussing	  chamber.	  We	  investigated	  whether	  paracrine	  regulation	  was	  responsible	  for	  this	  secretory	  phenotype,	  and	  not	  the	  virus	  infection	  itself,	  as	  modeled	  with	  the	  CM.	  	  Interestingly,	  we	  found	  that	  the	  secretory	  phenotype	  induced	  by	  the	  CM	  treatment	  was	  a	  result	  of	  concerted	  up-­‐regulation	  of	  KCNN4	  and	  KCNQ1.	  These	  potassium	  channels	  are	  responsible	  for	  generating	  the	  driving	  force	  for	  apical	  chloride	  secretion.	  Specific	  inhibition	  of	  these	  channels	  ameliorated	  the	  response,	  further	  indicating	  their	  importance	  in	  driving	  fluid	  secretion.	  Additionally,	  previous	  studies	  have	  shown	  that	  individual	  cytokines	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may	  have	  the	  capacity	  to	  modulate	  ion	  channel	  expression	  in	  airway	  epithelium;	  therefore,	  we	  dosed	  cells	  with	  IL-­‐8	  in	  order	  to	  assess	  whether,	  or	  not,	  this	  particular	  pro-­‐inflammatory	  cytokine	  would	  be	  able	  to	  reproduce	  the	  same	  effect	  as	  the	  conditioned	  media.	  IL-­‐8	  treatment	  did	  result	  in	  an	  increased	  secretory	  response;	  however,	  the	  underlying	  mechanism	  driving	  is	  not	  mediated	  through	  up-­‐regulated	  KCNN4	  and	  KCNQ1.	  	  
5.2.	  Introduction	  	   On	  an	  annual	  basis,	  influenza	  A	  virus	  is	  responsible	  for	  over	  half	  a	  million	  deaths	  due	  to	  complications	  related	  to	  mucus	  and	  fluid	  clearance[8].	  Appropriate	  fluid	  clearance	  from	  the	  lungs	  is	  essential	  for	  adequate	  gas	  exchange[31].	  	  Disruption	  of	  the	  mechanism	  driving	  fluid	  clearance	  results	  in	  the	  formation	  of	  pulmonary	  edema[33].	  This	  is	  particularly	  salient	  in	  severe	  infections	  where	  the	  inflammatory	  response	  initiated	  by	  infection	  of	  the	  upper	  airway	  epithelial	  cells	  quickly	  spreads	  to	  the	  lower	  airways,	  resulting	  in	  influenza-­‐induced	  Acute	  Respiratory	  Distress	  Syndrome	  (ARDS)[7,35].	  The	  ARDS	  is	  a	  result	  of	  a	  massive	  cascade	  of	  cytokines,	  both	  pro-­‐	  and	  anti-­‐inflammatory,	  flooding	  into	  the	  airways	  [48,107,108].	  Although	  the	  virus	  does	  not	  infect	  the	  majority	  of	  the	  cells	  in	  the	  airways,	  this	  cytokine	  cascade	  affects	  all	  of	  the	  epithelial	  cells,	  which	  control	  the	  movement	  of	  fluid[132].	  Upon	  infection	  with	  influenza,	  the	  airway	  epithelial	  cells,	  along	  with	  inflammatory	  cells	  (e.g.,	  macrophages),	  generate	  a	  large	  proportion	  of	  the	  cascade[10,13].	  Individually,	  a	  number	  of	  these	  cytokines	  have	  been	  shown	  to	  impact	  epithelial	  ion	  transport;	  however,	  the	  combined	  effects	  that	  would	  arise	  during	  an	  influenza	  infection,	  have	  not	  been	  investigated[48,107,108,109].	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   Ion	  transport	  across	  the	  epithelial	  barrier	  creates	  the	  osmotic	  drive	  to	  control	  fluid	  movement	  in	  and	  out	  of	  the	  airways[11,28,130].	  The	  driving	  force	  for	  movement	  of	  ions	  and	  fluid	  in	  all	  epithelial	  cells	  is	  generated	  by	  the	  electrochemical	  gradient	  of	  the	  3Na+/2K+-­‐ATPase	  pump	  (ATP1A1)[11].	  This	  creates	  a	  negative	  internal	  potential:	  high	  internal	  potassium	  concentration	  paired	  with	  a	  low	  concentration	  of	  sodium[21,104].	  The	  negative	  membrane	  potential	  drives	  chloride	  out	  of	  the	  cell	  apically,	  pulling	  sodium	  and	  water	  along	  with	  it[104].	  The	  majority	  of	  this	  apical	  anion	  secretion	  is	  through	  the	  cAMP-­‐activated	  cystic	  fibrosis	  transmembrane	  regulator	  channel,	  CFTR[22,97,141].	  Chloride	  movement	  is	  also	  facilitated	  through	  the	  TMEM16	  family	  of	  calcium-­‐activated	  chloride	  channels	  (CaCC)[24,25,142].	  The	  electrochemical	  gradient	  driving	  chloride	  out	  through	  these	  channels	  leads	  to	  airway	  hydration.	  The	  chloride	  lost	  apically	  is	  subsequently	  replenished	  on	  the	  basolateral	  side	  through	  the	  Na+-­‐K+-­‐2Cl-­‐	  co-­‐transporter	  (NKCC1).	  This	  net	  secretion	  can	  be	  increased	  by	  activation	  of	  potassium	  channels,	  which	  facilitate	  K+	  efflux,	  which	  further	  depolarizes	  the	  membrane	  and	  increases	  chloride	  secretion.	  [69,143,144].	  Airway	  epithelial	  cells	  have	  two	  major	  potassium	  channels,	  namely	  KCNN4	  (calcium-­‐activated),	  and	  KCNQ1	  (cAMP-­‐activated)[89,100].	  	  	   Previously,	  we	  have	  shown	  that	  if	  every	  cell	  is	  infected	  with	  influenza	  virus,	  we	  observe	  a	  decrease	  in	  net	  secretion	  after	  48	  hours	  of	  infection	  (see	  chapter	  3;	  Figure	  10	  A,	  B).	  This	  was	  a	  result	  of	  down-­‐regulation	  of	  CFTR,	  and	  KCNN4	  protein	  (Figure	  10F).	  However,	  if	  we	  reduce	  the	  viral	  dose,	  recapitulating	  the	  situation	  in	  the	  airways	  where	  not	  all	  of	  the	  cells	  are	  infected,	  there	  is	  an	  observed	  increase	  in	  net	  secretion	  primarily	  driven	  through	  KCNN4	  (see	  chapter	  3;	  Figure	  11C,	  I).	  This	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effect	  also	  correlated	  with	  an	  increase	  in	  the	  relative	  transcript	  levels	  for	  various	  pro-­‐inflammatory	  cytokines,	  including	  IL-­‐6,	  IL-­‐8,	  IL-­‐1β,	  IL-­‐1α,	  IL-­‐12α	  and	  TNF-­‐α,	  which	  are	  secreted	  by	  the	  infected	  epithelial	  cells	  (Figure	  11G).	  The	  majority	  of	  this	  response	  is	  pro-­‐inflammatory;	  however,	  we	  speculate	  that	  the	  observed	  increase	  in	  fluid	  secretion	  is	  driven	  by	  a	  combination	  of	  these	  cytokines	  acting	  in	  a	  paracrine	  manner	  on	  non-­‐infected	  cells.	  This	  mirrors	  what	  occurs	  in	  vivo,	  as	  the	  massive	  fluid	  secretion	  leading	  to	  ARDS	  is	  a	  result	  of	  a	  cytokine	  cascade	  that	  presumably	  includes	  multiple	  different	  inflammatory	  mediators[115,145,146].	  In	  this	  study,	  we	  wanted	  to	  assess	  the	  impact	  of	  conditioned	  media	  (CM)	  containing	  these	  cytokines	  on	  Calu3	  cell	  fluid	  secretion.	  This	  model	  allows	  us	  to	  study	  the	  impact	  of	  the	  inflammatory	  cytokines	  in	  the	  absence	  of	  the	  virus.	  Additionally,	  we	  test	  whether	  an	  individual	  pro-­‐inflammatory	  cytokine,	  IL-­‐8,	  can	  independently	  mediate	  a	  secretory	  response.	  	  
5.3.	  Material	  and	  Methods	  
Refer	  to	  Chapter	  2	  
5.4.	  Results	  	   Here	  we	  exposed	  polarized	  Calu3	  cells	  to	  conditioned	  media	  (CM),	  which	  contains	  the	  secreted	  inflammatory	  mediators	  induced	  by	  influenza	  virus	  infection	  of	  epithelial	  cells.	  The	  goal	  was	  to	  assess	  whether	  the	  release	  of	  cytokines	  from	  infected	  cells	  would	  be	  capable	  of	  paracrine	  stimulation	  of	  non-­‐infected	  cells,	  leading	  to	  a	  secretory	  phenotype.	  Polarized	  Calu3	  cells	  were	  exposed	  both	  apically	  and	  basolaterally	  with	  UV-­‐inactivated	  viral	  conditioned	  media	  (VCM;	  see	  chapter	  2	  section	  2.3.)	  or	  control	  conditioned	  media	  (CCM)	  for	  48	  hours.	  This	  time	  point	  was	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selected	  in	  order	  to	  be	  comparable	  to	  our	  previous	  data	  where	  we	  saw	  an	  increased	  secretory	  response	  in	  cells	  infected	  at	  an	  MOI	  of	  0.6	  for	  48	  hours	  (Figure	  11C).	  	  	   We	  found	  that	  the	  cells	  treated	  for	  48	  hours	  with	  VCM	  had	  significantly	  increased	  calcium-­‐activated	  Isc	  (p	  <	  0.001)	  with	  no	  change	  in	  cAMP-­‐activated	  Isc	  when	  compared	  to	  controls	  (Figure	  13A).	  Additionally,	  no	  change	  in	  measurable	  Isc	  for	  cAMP-­‐	  or	  calcium-­‐activated	  chloride	  conductance	  was	  detected	  after	  inhibition	  with	  glibenclamide	  or	  niflumic	  acid,	  respectively	  (Figure	  13B).	  A	  possible	  mechanism	  to	  explain	  this	  increased	  driving	  force	  for	  apical	  chloride	  secretion	  includes	  up-­‐regulated	  levels	  of	  either	  NKCC1	  and/or	  ATP1A1.	  However,	  mRNA	  levels	  of	  both	  of	  these	  transporters	  were	  not	  significantly	  increased	  (Figure	  13D).	  Alternatively,	  increased	  chloride	  conductance	  through	  CFTR	  could	  account	  for	  the	  observed	  effect;	  however,	  the	  mRNA	  levels	  of	  CFTR	  remained	  unchanged	  (Figure	  13D).	  Further	  molecular	  analysis	  revealed	  that	  there	  was	  a	  significant	  2-­‐fold	  increase	  in	  KCNN4	  and	  KCNQ1	  mRNA	  in	  the	  VCM	  treated	  cells	  (p	  =	  0.039;	  p	  =	  0.017,	  respectively;	  Figure	  13D).	  This	  correlated	  with	  a	  significant	  increase	  in	  KCNN4	  protein	  (p	  =	  0.002;	  Figure	  13F),	  giving	  a	  plausible	  explanation	  for	  the	  observed	  increase	  in	  calcium-­‐activated	  Isc.	  With	  no	  difference	  in	  the	  KCNQ1-­‐stimulated	  Isc,	  as	  indicated	  by	  addition	  of	  forskolin	  and	  IBMX,	  we	  assessed	  whether	  the	  channel	  subunits,	  KCNE2	  and	  KCNE3,	  were	  present.	  Both	  subunits	  are	  essential	  in	  maintaining	  a	  cAMP-­‐stimulated	  Isc[89];	  however,	  neither	  one	  was	  detectable	  via	  RT-­‐qPCR,	  despite	  using	  previously	  published	  primers[65],	  and	  multiple	  attempts	  using	  newly	  designed	  primers.	  Additionally,	  the	  KCNQ1	  channel	  protein	  was	  below	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detectable	  limits	  when	  using	  western	  blotting	  techniques.	  This	  is	  a	  possible	  explanation	  for	  detecting	  no	  difference	  in	  the	  cAMP-­‐stimulated	  Isc.	  In	  order	  to	  assess	  whether	  pro-­‐inflammatory	  cytokines	  may	  be	  responsible	  for	  driving	  this	  increased	  secretory	  response,	  we	  quantified	  and	  compared	  cytokine	  protein	  levels	  in	  the	  VCM	  relative	  to	  CCM	  using	  the	  Bio-­‐Plex	  suspension	  array	  assay.	  Cells	  treated	  with	  VCM	  were	  exposed	  to	  a	  strong,	  pro-­‐inflammatory	  cytokine	  mixture,	  with	  elevated	  levels	  of	  IL-­‐6,	  IL-­‐8,	  and	  TNF-­‐α	  (p	  <	  0.001	  for	  all;	  Figure	  13E).	  	  With	  levels	  of	  KCNQ1	  mRNA	  increased,	  but	  without	  detectable	  protein,	  we	  wanted	  to	  establish	  whether	  or	  not	  KCNQ1	  was	  present	  in	  our	  cell	  model	  due	  to	  previous	  reports;	  therefore,	  we	  inhibited	  its	  potential	  contribution	  to	  Isc	  with	  chromanol	  293B	  (Figure	  14)[147].	  Expectedly,	  chromanol	  293B	  inhibition	  decreased	  the	  cAMP-­‐mediated	  Isc	  by	  59%	  (p	  =	  0.07;	  Figure	  14A).	  Additionally,	  there	  was	  a	  significant	  decrease	  in	  the	  glibenclamide-­‐inhibitable	  Isc	  (p	  =	  0.029)	  suggesting	  that	  cAMP-­‐mediated	  chloride	  secretion	  depends	  on	  KCNQ1	  potassium	  conductance	  (Figure	  14B).	  Surprisingly,	  chromanol	  293B	  inhibition	  also	  resulted	  in	  a	  significant	  decrease	  in	  calcium-­‐activated	  Isc	  (p	  =	  0.003;	  Figure	  14A).	  This	  suggests	  that	  the	  increase	  in	  apical	  calcium-­‐activated	  chloride	  secretion	  is	  dependent	  on	  KCNQ1.	  We	  speculated	  that	  both	  KCNQ1	  and	  KCNN4	  are	  required	  in	  order	  to	  see	  the	  overall	  net	  increase	  in	  anion	  secretion,	  as	  observed	  after	  treatment	  with	  conditioned	  media	  (Figure	  13A).	  	  	   We	  then	  sought	  to	  investigate	  the	  physiological	  contribution	  of	  KCNN4	  to	  the	  
Isc	  in	  conditioned	  media	  treated	  cells	  using	  the	  channel	  specific	  inhibitor	  TRAM-­‐34.	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Figure	  13.	  48	  hour	  CM	  treatment	  causes	  increase	  in	  calcium-­activated	  short-­
circuit	  current.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  control	  CM	  and	  virus	  CM.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  in	  control	  CM	  and	  virus	  CM	  (C).	  	  Change	  in	  ion	  channel	  and	  ion	  transporter	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  (D).	  	  Change	  in	  cytokine	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  (E).	  	  Western	  blot	  and	  densitometry	  of	  KCNN4	  (~45	  kDa)	  compared	  to	  GAPDH	  (~37	  kDa)	  reference	  (F).	  	  Isc	  =	  short-­‐circuit	  current;	  CM	  =	  conditioned	  media.	  Data	  presented	  as	  mean	  ±	  SEM,	  analyzed	  using	  t-­‐test.	  *	  =	  p	  <	  0.05;	  **	  =	  p	  <	  0.001	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Figure	  14.	  Chromanol	  293B	  inhibition	  reduces	  calcium-­activated	  current	  in	  
CM	  treated	  cells.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  control	  CM	  and	  virus	  CM	  exposed	  to	  the	  KCNQ1	  inhibitor	  chromanol	  293B	  or	  DMSO	  control.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  among	  control	  CM	  cells	  exposed	  to	  DMSO	  control	  (C)	  or	  chromanol	  293B	  inhibitor	  (D)	  and	  virus	  CM	  cells	  exposed	  to	  DMSO	  control	  (E)	  or	  chromanol	  293B	  inhibitor	  (F).	  Isc	  =	  short-­‐circuit	  current;	  	  CM	  =	  conditioned	  media.	  Data	  presented	  as	  mean	  ±	  SEM,	  analyzed	  using	  two-­‐way	  ANOVA	  with	  an	  interaction	  term.	  	  *	  =	  p	  <	  0.05	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Calcium-­‐activated	  Isc	  was	  significantly	  decreased	  upon	  inhibition,	  as	  expected	  (p	  <	  0.001),	  to	  a	  level	  that	  was	  equivalent	  between	  VCM	  and	  CCM	  treated	  cells	  (Figure	  15A).	  Inhibition	  of	  KCNN4	  will	  decrease	  the	  overall	  potassium-­‐related	  driving	  force	  on	  the	  basolateral	  membrane,	  thereby	  reducing	  the	  inhibitable	  CFTR-­‐mediated	  chloride	  current.	  	  We	  observed	  a	  decrease	  in	  the	  chloride	  current	  of	  approximately	  two-­‐thirds	  upon	  inhibition	  with	  glibenclamide	  (p	  <	  0.001;	  Figure	  15B).	  A	  minimal	  decrease	  was	  observed	  with	  niflumic	  acid,	  as	  there	  appeared	  to	  be	  less	  inhibitable	  chloride	  current	  relative	  to	  DMSO	  control	  cells	  (Figure	  15B).	  To	  further	  investigate	  the	  contribution	  of	  KCNN4,	  we	  utilized	  a	  more	  selective	  and	  potent	  inhibitor	  of	  this	  channel	  (ICA-­‐17043)[139,148].	  Inhibition	  with	  ICA-­‐17043	  significantly	  reduced	  the	  overall	  cAMP-­‐activated	  Isc	  (p	  =	  0.004;	  Figure	  16A).	  Correspondingly,	  the	  glibenclamide-­‐inhibitable	  current	  was	  significantly	  decreased,	  due	  to	  a	  reduced	  driving	  force	  (p	  =	  0.007;	  Figure	  16B).	  The	  calcium-­‐activated	  Isc	  in	  VCM	  treated	  cells	  was	  inhibited	  to	  a	  level	  below	  the	  CCM	  treated	  cells	  (p	  =	  0.019),	  with	  the	  overall	  reduction	  being	  94%	  and	  84%,	  respectively	  (p	  <	  0.001;	  Figure	  16A).	  	  Interestingly,	  the	  niflumic	  acid-­‐inhibitable	  current	  was	  larger	  in	  VCM	  treated	  cells	  than	  CCM	  treated	  cells	  (p	  =	  0.01;	  Figure	  16B).	  We	  speculate	  that	  this	  difference	  may	  be	  a	  result	  of	  the	  KCNQ1-­‐related	  potassium	  conductance	  from	  the	  basolateral	  membrane,	  as	  KCNQ1	  has	  been	  shown	  to	  have	  some	  basolateral	  localization,	  and	  is	  up-­‐regulated	  in	  the	  VCM	  treated	  cells[89,91].	  This	  would	  maintain	  the	  driving	  force	  for	  apically	  secreted	  chloride	  in	  the	  absence	  of	  KCNN4,	  and	  result	  in	  an	  increase	  in	  inhibitable	  current	  by	  niflumic	  acid	  in	  VCM	  treated	  cells.	  Therefore,	  we	  believe	  that	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Figure	  15.	  TRAM-­34	  inhibition	  of	  CM	  treated	  cells	  reduced	  the	  calcium-­
activated	  short-­circuit	  current.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  control	  CM	  and	  virus	  CM	  cells	  exposed	  to	  the	  KCNN4	  inhibitor	  TRAM-­‐34	  or	  DMSO	  control.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  among	  control	  CM	  cells	  exposed	  to	  DMSO	  control	  (C)	  or	  TRAM-­‐34	  inhibitor	  (D)	  and	  virus	  CM	  cells	  exposed	  to	  DMSO	  control	  (E)	  or	  TRAM-­‐34	  inhibitor	  (F).	  Isc	  =	  short-­‐circuit	  current;	  CM	  =	  conditioned	  media.	  Data	  presented	  as	  mean	  ±	  SEM,	  analyzed	  using	  two-­‐way	  ANOVA	  with	  an	  interaction	  term.	  	  **	  =	  p	  <	  0.001	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  basolaterally-­‐located	  KCNQ1	  has	  a	  marginal	  contribution	  to	  the	  apical	  chloride	  secretion,	  with	  complete	  inhibition	  of	  KCNN4.	  	   Interleukin-­‐8	  is	  a	  strong,	  pro-­‐inflammatory	  cytokine	  that	  is	  highly	  expressed	  by	  epithelial	  cells	  during	  viral	  infection[56,106].	  Since	  the	  direct	  effects	  of	  IL-­‐8	  have	  not	  yet	  been	  studied	  in	  epithelial	  cells,	  we	  sought	  to	  characterize	  the	  role	  that	  this	  single,	  pro-­‐inflammatory	  cytokine	  has	  in	  modulating	  anion	  secretion	  in	  Calu3	  cells,	  using	  a	  dose-­‐response	  (low	  (10),	  medium	  (100)	  and	  high	  (1000)	  ng/ml).	  	  	   	  Treatment	  of	  cells	  for	  48	  hours	  with	  IL-­‐8	  produced	  a	  strong	  pro-­‐secretory	  response	  as	  evidenced	  by	  a	  significantly	  increased	  calcium-­‐activated	  Isc	  at	  low,	  medium	  and	  high	  doses	  (p	  <	  0.001,	  0.012,	  0.002,	  respectively;	  Figure	  17A).	  There	  was	  no	  change	  in	  the	  cAMP-­‐stimulated	  Isc	  for	  any	  of	  the	  doses	  of	  IL-­‐8.	  However,	  the	  high	  dose	  resulted	  in	  a	  significant	  reduction	  in	  inhibitable	  chloride	  conductance,	  for	  both	  glibenclamide	  (p	  =	  0.002)	  and	  niflumic	  acid	  (p	  =	  0.011;	  Figure	  17B).	  This	  decrease	  in	  chloride	  conductance	  is	  likely	  a	  result	  of	  a	  significant	  decrease	  in	  the	  basolateral	  supply	  of	  chloride	  into	  the	  cell	  by	  NKCC1	  and	  not	  due	  to	  a	  decrease	  in	  CFTR,	  as	  no	  change	  was	  noted	  in	  the	  mRNA	  (Figure	  17D).	  Additionally,	  RT-­‐qPCR	  analysis	  for	  the	  other	  ion	  channels	  under	  study	  showed	  no	  change	  in	  mRNA;	  however,	  there	  was	  a	  significant	  decrease	  in	  KCNN4	  mRNA	  after	  treatment	  with	  the	  high	  dose	  of	  IL-­‐8	  (Figure	  17D).	  Interestingly,	  the	  low	  dose	  of	  IL-­‐8	  increased	  mRNA	  levels	  of	  the	  pro-­‐inflammatory	  cytokines	  IFN-­‐α,	  TNF-­‐α,	  IL-­‐1β	  and	  IL-­‐1α	  (Figure	  17E).	  This	  demonstrates	  that	  IL-­‐8,	  by	  itself,	  is	  not	  able	  to	  recapitulate	  the	  cellular	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Figure	  16.	  ICA-­17043	  inhibition	  reduces	  overall	  short-­circuit	  current	  in	  CM	  
treated	  cells.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  control	  CM	  and	  virus	  CM	  cells	  exposed	  to	  the	  KCNN4	  inhibitor	  ICA-­‐17043	  or	  DMSO	  control.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  among	  control	  CM	  cells	  exposed	  to	  DMSO	  control	  (C)	  or	  ICA-­‐17043	  inhibitor	  (D)	  and	  virus	  CM	  cells	  exposed	  to	  DMSO	  control	  (E)	  or	  TRAM-­‐34	  inhibitor	  (F).	  	  Isc	  =	  short-­‐circuit	  current;	  CM	  =	  conditioned	  media.	  Data	  presented	  as	  mean	  ±	  SEM,	  analyzed	  using	  two-­‐way	  ANOVA	  with	  an	  interaction	  term.	  *	  =	  p	  <	  0.05;	  **	  =	  p	  <	  0.001	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physiological	  effects	  of	  the	  conditioned	  media,	  which	  contains	  multiple	  different	  cytokines.	  	  
5.5.	  Discussion	  	   Calu3	  cells	  treated	  with	  VCM	  for	  48	  hours	  produced	  a	  robust	  secretory	  response	  (Figure	  13A).	  Molecular	  analysis	  of	  mRNA	  and	  protein	  indicates	  that	  KCNN4	  is	  up-­‐regulated,	  which	  is	  in	  agreement	  with	  our	  previous	  study	  (see	  chapter	  3).	  A	  plausible	  mechanism	  for	  the	  increased	  secretory	  response	  is	  the	  up-­‐regulation	  of	  NKCC1	  and/or	  ATP1A1.	  The	  Na+-­‐K+-­‐ATPase	  (ATP1A1)	  creates	  the	  electrochemical	  gradient	  for	  the	  apical	  movement	  of	  chloride	  and	  up-­‐regulation	  of	  this	  pump	  would	  result	  in	  an	  increased	  driving	  force	  for	  chloride	  secretion[11].	  Similarly,	  the	  Na+-­‐K+-­‐2Cl-­‐	  co-­‐transporter	  (NKCC1)	  replenishes	  intracellular	  stores	  of	  these	  ions,	  so	  any	  increase	  in	  activity	  would	  result	  in	  more	  driving	  force	  for	  apical	  secretion[11].	  Since	  we	  did	  not	  detect	  changes	  in	  expression	  of	  either	  of	  these	  transporters	  it	  is	  unlikely	  that	  they	  are	  responsible	  for	  driving	  the	  increased	  fluid	  secretion.	  Therefore,	  we	  further	  investigated	  the	  contribution	  of	  KCNN4	  to	  this	  process.	  	  	   Using	  two	  selective	  inhibitors	  of	  KCNN4,	  we	  demonstrated	  that	  the	  increase	  in	  apical	  chloride	  secretion	  could	  be	  ameliorated.	  TRAM-­‐34	  significantly	  decreased	  the	  calcium-­‐activated	  Isc	  and	  the	  more	  potent	  inhibitor,	  ICA-­‐17043	  showed	  further	  reduction	  in	  the	  Isc	  to	  levels	  below	  the	  CCM	  treated	  cells.	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Figure	  17.	  IL-­8	  dose	  response	  leads	  to	  physiological	  increase	  in	  calcium-­
activated	  short-­circuit	  current.	  Change	  in	  Isc	  in	  response	  to	  the	  addition	  of	  ion	  channel	  activators	  (forskolin/IBMX	  and	  A23187;	  A)	  or	  inhibitors	  (glibenclamide	  and	  niflumic	  acid;	  B)	  in	  cells	  treated	  with	  IL-­‐8.	  	  Experimental	  Isc	  traces	  representing	  cellular	  responses	  to	  activating	  and	  inhibiting	  drugs	  in	  cells	  treated	  with	  IL-­‐8	  (C).	  	  Change	  in	  ion	  channel	  and	  ion	  transporter	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  (D).	  	  Change	  in	  cytokine	  mRNA,	  as	  measured	  by	  RT-­‐qPCR	  (E).	  	  Isc	  =	  short-­‐circuit	  current;	  CFTR	  =	  cystic	  fibrosis	  transmembrane	  regulator;	  NKCC1	  =	  Na+-­‐K+-­‐2Cl-­‐	  cotransporter;	  ATP1A1	  =	  Na+-­‐K+	  ATPase.	  Data	  presented	  as	  mean	  ±	  SEM.	  T-­‐tests	  were	  used	  to	  compare	  control	  cells	  to	  each	  dose	  of	  IL-­‐8.	  To	  protect	  against	  an	  inflated	  type	  I	  error	  rate	  due	  to	  multiple	  comparisons,	  the	  Bonferroni	  correction	  was	  used	  to	  reduce	  the	  individual	  test	  alpha	  level	  to	  0.0167;	  *	  =	  p	  <	  0.05	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The	  role	  of	  KCNN4	  is	  to	  establish	  the	  driving	  force	  for	  apical	  chloride	  secretion[65].	  Therefore,	  our	  ability	  to	  inhibit	  KCNN4	  indicates	  that	  the	  increased	  secretory	  response	  in	  VCM	  treated	  cells	  is	  closely	  linked	  to	  increases	  in	  KCNN4	  expression.	  	  	  	   KCNN4,	  also	  referred	  to	  as	  the	  Gardos	  channel,	  is	  a	  calcium-­‐activated	  potassium	  channel	  found	  in	  red	  blood	  cells,	  and	  multiple	  different	  tissues[139,148,149,150].	  In	  epithelial	  cells,	  it	  is	  primarily	  found	  on	  the	  basolateral	  membrane,	  and	  is	  highly	  expressed	  in	  Calu3	  cells[63,65].	  Activation	  of	  KCNN4	  is	  mediated	  through	  increases	  in	  intracellular	  calcium	  levels	  resulting	  in	  an	  increased	  driving	  force	  for	  apical	  chloride	  secretion[63,69].	  Previously	  it	  was	  believed	  that	  the	  basolateral	  recycling	  of	  potassium	  through	  KCNN4	  and	  the	  Na+-­‐K+-­‐ATPase	  was	  solely	  responsible	  for	  driving	  apical	  anion	  secretion	  in	  the	  upper	  airways[100,101].	  However,	  this	  model	  has	  been	  updated	  to	  include	  an	  apical	  potassium	  conductance	  in	  addition	  to	  basolateral	  conductance[87,89,104].	  	  	   KCNQ1	  is	  a	  cAMP-­‐activated	  potassium	  channel	  that	  is	  highly	  expressed	  in	  cardiac	  tissue	  and	  various	  epithelium[151].	  In	  Calu3	  cells,	  KCNQ1	  has	  been	  identified	  as	  the	  major	  apical	  potassium	  channel,	  with	  some	  basolateral	  localization[65,89].	  In	  response	  to	  VCM	  treatment,	  we	  detected	  increased	  mRNA	  levels	  of	  KCNQ1.	  A	  limitation	  is	  that	  we	  were	  unable	  to	  detect	  the	  associated	  protein	  via	  western	  blot	  despite	  using	  three	  different	  protein	  extraction	  methods,	  and	  two	  different	  primary	  antibodies,	  one	  of	  which	  had	  been	  previously	  shown	  to	  work	  in	  a	  Calu3	  cell	  model[89].	  To	  address	  this,	  we	  used	  the	  KCNQ1-­‐specific	  inhibitor,	  chromanol	  293B[89,147]	  to	  eliminate	  the	  potential	  contribution	  of	  KCNQ1	  to	  the	  overall	  Isc.	  Successful	  reduction	  in	  the	  calcium-­‐activated	  Isc	  indicates	  that	  KCNQ1	  can	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be	  inhibited	  pharmacologically.	  With	  both	  physiology	  and	  gene	  expression	  data	  in	  support	  of	  the	  presence	  of	  KCNQ1,	  we	  sought	  to	  identify	  its	  associated	  subunits	  KCNE2	  and	  KCNE3.	  Several	  attempts	  were	  made	  to	  detect	  both	  KCNE2	  and	  KCNE3	  in	  our	  model	  using	  RT-­‐qPCR	  techniques;	  however,	  we	  were	  unable	  to	  successfully	  detect	  the	  presence	  of	  these	  subunits	  despite	  using	  our	  own	  primers	  and	  previously	  published	  primers[65].	  This	  negative	  result	  may	  explain	  why	  stimulation	  with	  forskolin	  and	  IBMX	  did	  not	  result	  in	  an	  increased	  cAMP-­‐activated	  Isc,	  despite	  increased	  levels	  of	  KCNQ1	  mRNA	  (Figure	  13A),	  as	  Moser	  et	  al.	  describes	  that	  association	  of	  KCNQ1	  with	  its	  subunits	  allows	  for	  the	  generation	  of	  a	  cAMP-­‐stimulated	  current[89].	  Additionally,	  the	  likely	  presence	  of	  KCNQ1	  helps	  to	  explain	  the	  observations	  from	  the	  inhibition	  of	  KCNN4	  using	  ICA-­‐17043	  (Figure	  16B).	  We	  observed	  that	  after	  removing	  the	  effect	  of	  KCNN4,	  there	  was	  a	  remaining,	  niflumic	  acid-­‐inhibitable	  current	  in	  the	  VCM	  treated	  cells.	  This	  could	  be	  attributed	  to	  basolaterally	  localized	  KCNQ1,	  as	  this	  may	  provide	  enough	  driving	  force,	  along	  with	  the	  up-­‐regulation,	  to	  increase	  chloride	  secretion	  in	  the	  absence	  of	  KCNN4.	  	  	  	   Calu3	  cells	  have	  already	  been	  shown	  to	  express	  functional	  potassium	  channels[65,87,89].	  Our	  data	  supports	  the	  presence	  of	  both	  KCNN4	  and	  KCNQ1,	  which	  are	  major	  contributors	  to	  the	  overall	  driving	  force	  for	  apical	  anion	  secretion[65,89].	  	  Located	  on	  the	  basolateral	  membrane,	  KCNN4	  is	  responsible	  for	  recycling	  potassium	  back	  out	  of	  the	  cell	  in	  response	  to	  the	  active	  pumping	  of	  the	  Na+-­‐K+-­‐ATPase[100].	  Apically,	  KCNQ1	  works	  in	  a	  similar	  fashion	  to	  drive	  potassium	  out	  of	  the	  cell[89].	  The	  combined	  effect	  of	  these	  two	  channels	  creates	  the	  driving	  force	  for	  apical	  chloride	  secretion	  via	  CFTR.	  The	  increase	  in	  potassium	  channels	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induced	  by	  the	  VCM	  therefore	  results	  in	  more	  chloride	  secretion	  and	  the	  development	  of	  a	  secretory	  phenotype.	  Our	  data	  further	  suggests	  that	  the	  secretory	  response	  can	  be	  ameliorated	  upon	  channel-­‐specific	  inhibition.	  However,	  both	  channels	  are	  required	  in	  order	  to	  observe	  the	  secretory	  phenotype	  (Figure	  18).	  This	  agrees	  with	  the	  theoretical	  model	  of	  Cook	  et	  al.,	  which	  describes	  the	  presence	  of	  an	  apical	  potassium	  channel	  in	  concert	  with	  a	  basolateral	  potassium	  conductance	  in	  order	  to	  facilitate	  optimal	  conditions	  for	  the	  apical	  secretion	  of	  chloride[104].	  The	  apical	  potassium	  efflux	  maintains	  hyperpolarizing	  conditions	  at	  the	  apical	  membrane	  and	  reduces	  the	  likelihood	  that	  chloride	  will	  reach	  its	  equilibrium	  gradient;	  therefore,	  maintaining	  a	  net	  apical	  secretion	  of	  anions[89,104].	  	   Our	  results	  demonstrate,	  so	  far,	  that	  the	  pro-­‐inflammatory	  cytokine	  mixture	  is	  capable	  of	  driving	  increased	  Isc,	  which	  is	  dependent	  on	  the	  combined	  up-­‐regulation	  of	  KCNQ1	  and	  KCNN4.	  Studies	  have	  shown	  that	  prolonged	  exposure	  to	  certain	  pro-­‐inflammatory	  cytokines,	  such	  as	  TNF-­‐α	  and	  IL-­‐1β,	  cause	  a	  decrease	  in	  the	  absorptive	  capacity	  of	  the	  epithelium[48,58,59].	  Additionally,	  high	  doses	  of	  anti-­‐inflammatory	  cytokines,	  including	  IL-­‐4	  and	  IL-­‐13,	  lead	  to	  increased	  chloride	  secretion	  through	  up-­‐regulation	  of	  CFTR,	  and	  CaCC	  [107,108].	  However,	  individual	  cytokines	  act	  on	  a	  variety	  of	  cellular	  receptors	  and	  often	  initiate	  different	  signal	  transduction	  pathways[152].	  For	  instance,	  anti-­‐inflammatory	  cytokines	  such	  as	  IL-­‐4	  result	  in	  dampening	  of	  the	  immune	  response	  and	  tissue	  repair	  whereas	  IL-­‐8,	  a	  pro-­‐inflammatory	  cytokine,	  leads	  to	  immune	  cell	  recruitment	  and	  heightening	  of	  the	  inflammatory	  response[106,108]	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Figure	  18.	  Proposed	  mechanism	  of	  changes	  in	  short-­circuit	  current	  resulting	  
from	  pro-­inflammatory	  paracrine	  signaling	  among	  non-­infected	  airway	  
epithelial	  cells.	  Influenza	  A	  virus	  infection	  of	  the	  upper	  respiratory	  tract	  leads	  to	  the	  production	  and	  secretion	  of	  pro-­‐inflammatory	  cytokines.	  Many	  different	  cytokines	  are	  released	  by	  the	  infected	  epithelium,	  and	  since	  not	  all	  of	  the	  cells	  are	  infected,	  these	  immune	  mediating	  cytokines	  act	  in	  a	  paracrine	  fashion	  on	  non-­‐infected	  cells.	  We	  have	  detected,	  using	  a	  mixture	  of	  cytokines	  on	  non-­‐infected	  cells	  (i.e.,	  the	  conditioned	  media)	  an	  up-­‐regulation	  of	  KCNN4	  mRNA	  and	  protein,	  as	  well	  as	  increased	  KCNQ1	  mRNA	  expression.	  The	  outward	  movement	  of	  potassium	  hyperpolarizes	  the	  cell,	  which	  increases	  the	  driving	  force	  for	  anion	  secretion	  (chloride).	  Up-­‐regulation	  of	  these	  channels	  results	  in	  an	  increased	  driving	  force	  for	  chloride	  efflux	  through	  CFTR,	  thereby	  increasing	  the	  overall	  fluid	  secretion	  into	  the	  airways.	  The	  presence	  of	  both	  apical	  and	  basolateral	  potassium	  conductance	  is	  necessary	  in	  order	  to	  generate	  enough	  driving	  force	  to	  increase	  apical	  anion	  secretion.	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Other	  cytokines,	  such	  as	  IL-­‐6,	  which	  seem	  to	  sit	  in	  the	  middle	  of	  this	  spectrum,	  can	  mediate	  both	  a	  pro-­‐	  and	  anti-­‐inflammatory	  response[56].	  This	  demonstrates	  that	  cytokines	  may	  have	  varying	  effects	  depending	  on	  whether	  they	  are	  acting	  independently,	  or	  in	  concert	  with	  one	  another.	  	   	  	   The	  pro-­‐inflammatory	  cytokine,	  IL-­‐8,	  is	  ubiquitously	  and	  consistently	  secreted	  upon	  infection	  with	  varying	  strains	  of	  influenza	  virus,	  making	  it	  an	  ideal	  candidate	  for	  assessing	  whether	  a	  single	  pro-­‐inflammatory	  cytokine	  is	  capable	  of	  inducing	  the	  same	  response	  as	  the	  CM[56,106,115,153].	  Additionally,	  the	  direct	  effects	  of	  IL-­‐8	  have	  not	  yet	  been	  studied	  in	  epithelial	  cells	  even	  though	  it	  is	  a	  key	  cytokine	  involved	  in	  immune	  regulation	  and	  inflammation[56,106,115].	  A	  48-­‐hour	  dose	  response	  of	  IL-­‐8	  on	  Calu3	  cells	  resulted	  in	  an	  increased	  calcium-­‐activated	  Isc,	  similar	  to	  the	  conditioned	  media	  (Figure	  17A).	  In	  contrast	  to	  the	  conditioned	  media,	  IL-­‐8	  treatment	  did	  not	  result	  in	  up-­‐regulation	  of	  KCNN4	  and	  KCNQ1,	  indicating	  that	  the	  IL-­‐8-­‐induced	  hypersecretory	  phenotype	  is	  mediated	  through	  a	  separate	  mechanism.	  In	  fact,	  KCNN4	  and	  NKCC1	  mRNA	  levels	  were	  down-­‐regulated,	  but	  only	  at	  the	  high	  dose	  of	  IL-­‐8.	  This	  drastic	  difference	  between	  the	  IL-­‐8	  treated	  cells	  and	  the	  VCM	  treated	  cells	  highlights	  the	  inadequacy	  of	  reducing	  a	  complex,	  paracrine	  regulation	  system	  down	  to	  a	  single	  contributing	  factor.	  Additionally,	  the	  IL-­‐8	  results	  varied	  by	  dose,	  suggesting	  that	  physiological	  changes	  may	  be	  influenced	  by	  cytokine	  concentration.	  These	  observations	  imply	  that	  paracrine	  regulation	  of	  epithelial	  cells	  depends	  on	  both	  the	  presence	  of	  multiple	  different	  cytokines,	  as	  well	  as	  their	  relative	  concentrations.	  Future	  research	  could	  explore	  the	  possible	  interaction	  between	  cytokines	  and	  their	  effect	  on	  cell	  secretory	  behavior;	  however,	  this	  is	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beyond	  the	  scope	  of	  this	  study.	  	  	   Additional	  applications	  that	  could	  be	  considered	  by	  future	  research	  include	  treatment	  of	  influenza-­‐induced	  ARDS	  with	  the	  clinically	  available	  drug,	  ICA-­‐17043[139].	  This	  compound	  is	  currently	  in	  phase	  3	  clinical	  trials	  for	  the	  treatment	  of	  sickle	  cell	  anemia[148,149].	  Since	  the	  underlying	  mechanism	  causing	  cell	  sickling	  is	  dependent	  on	  KCNN4	  (the	  Gardos	  channel)	  there	  may	  be	  additional	  therapeutic	  benefits	  of	  ICA-­‐17043	  in	  treatment	  of	  acute	  flu.	  Overall,	  our	  data	  suggest	  that	  the	  pro-­‐inflammatory	  cytokines	  secreted	  by	  infected	  epithelial	  cells	  are	  capable	  of	  inducing	  a	  secretory	  response	  independently	  of	  the	  virus.	  The	  concerted	  up-­‐regulation	  of	  KCNN4	  and	  KCNQ1	  after	  CM	  treatment	  indicates	  that	  both	  of	  these	  channels	  are	  required	  to	  increase	  apical	  chloride	  secretion.	  IL-­‐8	  treatment	  resulted	  in	  a	  similar	  increase	  in	  secretory	  phenotype;	  however,	  the	  underlying	  mechanism	  remains	  to	  be	  uncovered,	  as	  it	  is	  not	  a	  result	  of	  increased	  KCNN4	  or	  KCNQ1.	  This	  study	  reveals	  the	  impact	  cytokine	  expression	  levels	  have	  on	  airway	  epithelial	  cell	  secretion,	  and	  strongly	  suggest	  a	  role	  for	  the	  host	  immune	  response	  in	  driving	  the	  pathogenesis	  of	  influenza	  virus.	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CHAPTER	  6.	  GENERAL	  DISCUSSION	  AND	  CONCLUSION	  
	   The	  main	  purpose	  of	  this	  study	  was	  to	  identify	  the	  direct	  and	  indirect	  effects	  of	  influenza	  virus	  infection	  on	  chloride	  and	  potassium	  channel	  function.	  In	  order	  to	  study	  the	  virus-­‐specific	  effects,	  we	  infected	  Calu3	  cells	  directly	  at	  varying	  doses	  and	  assessed	  changes	  in	  ion	  transport	  in	  addition	  to	  measuring	  the	  immune	  response	  (Objectives	  1	  and	  2).	  The	  indirect	  effects	  refer	  to	  the	  secondary	  impact	  of	  inflammatory	  cytokines,	  which	  are	  secreted	  by	  the	  infected	  cells	  and	  act	  in	  a	  paracrine	  manner	  to	  modulate	  ion	  transport	  in	  non-­‐infected	  cells.	  We	  assessed	  the	  impact	  of	  these	  inflammatory	  mediators	  independently	  from	  the	  virus	  by	  using	  cytokine-­‐containing	  conditioned	  media	  (Objectives	  3	  and	  4).	  Understanding	  what	  drives	  the	  pathogenesis	  of	  influenza	  is	  important	  in	  treating	  severe	  infections	  where	  the	  patient	  experiences	  flooding	  of	  fluid	  into	  the	  airways.	  	  	   Infection	  with	  influenza	  can	  lead	  to	  the	  development	  of	  ARDS	  and	  pulmonary	  edema[5,55,56].	  The	  mechanism	  driving	  this	  secretory	  response	  is	  unclear.	  The	  results	  presented	  here	  indicate	  that	  the	  immune	  response	  elicited	  by	  influenza	  infection	  lead	  to	  an	  up-­‐regulation	  of	  potassium	  channels,	  which	  drive	  anion	  secretion.	  Chapter	  3	  described	  the	  direct	  effects	  of	  viral	  infection	  on	  polarized	  Calu3	  cell	  monolayers.	  We	  found	  there	  was	  a	  strong	  pro-­‐inflammatory	  cytokine	  response	  from	  cells	  infected	  at	  an	  MOI	  of	  10,	  which	  also	  correlated	  with	  decreased	  epithelial	  resistance.	  This	  situation	  closely	  resembles	  that	  of	  severe	  influenza	  infections	  where	  an	  increased	  viral	  load	  overwhelms	  the	  host,	  resulting	  in	  cellular	  apoptosis	  and	  flooding	  of	  the	  lungs[154].	  More	  importantly,	  we	  determined	  a	  physiologically	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relevant	  dose	  of	  virus,	  which	  allowed	  us	  to	  study	  both	  direct	  and	  indirect	  (i.e.,	  cytokines)	  effects	  of	  influenza	  infection.	   	  	   The	  indirect	  effects	  of	  influenza	  infection	  were	  described	  in	  Chapter	  5	  where	  we	  studied	  the	  effect	  of	  cytokine-­‐containing	  conditioned	  media	  on	  non-­‐infected,	  polarized	  Calu3	  cell	  monolayers.	  This	  mirrors	  the	  situation	  observed	  during	  influenza	  infections	  where	  the	  majority	  of	  cells	  are	  not	  infected	  with	  the	  virus,	  but	  they	  are	  all	  exposed	  to	  the	  paracrine	  effects	  of	  inflammatory	  cytokine	  mediators	  from	  the	  infected	  cells[132,133].	  Using	  an	  MOI	  of	  0.6	  we	  demonstrated	  that	  when	  a	  large	  proportion	  of	  cells	  are	  not	  infected,	  but	  exposed	  to	  paracrine	  regulation	  from	  infected	  cells,	  the	  epithelium	  as	  a	  whole	  develops	  a	  secretory	  phenotype.	  	  Based	  on	  the	  analysis	  of	  mRNA	  and	  protein	  we	  concluded	  this	  effect	  to	  be	  driven	  mainly	  by	  increased	  basolateral	  potassium	  conductance	  through	  up-­‐regulation	  of	  KCNN4	  (see	  chapter	  3).	  Chapter	  5	  investigated	  whether	  the	  paracrine	  regulation	  was	  responsible	  for	  this	  observed	  secretory	  phenotype,	  and	  not	  the	  virus	  infection	  itself.	  The	  use	  of	  conditioned	  media	  represents	  the	  physiological	  mixture	  of	  cytokines	  that	  would	  be	  present	  during	  influenza	  infection,	  and	  allowed	  us	  to	  study	  the	  effects	  of	  cytokines	  independently	  from	  the	  virus.	  	  	   	  	   Previous	  studies	  have	  shown	  that	  individual	  cytokines	  may	  have	  the	  capacity	  to	  modulate	  ion	  channel	  expression[48,107]	  in	  airway	  epithelium;	  therefore,	  we	  dosed	  cells	  with	  IL-­‐8	  in	  order	  to	  assess	  whether,	  or	  not,	  this	  particular	  pro-­‐inflammatory	  cytokine	  would	  be	  able	  to	  reproduce	  the	  same	  effect	  as	  the	  conditioned	  media	  (Objective	  4).	  	  We	  conclude	  from	  our	  data	  that	  a	  dose	  response	  of	  IL-­‐8	  was	  able	  to	  induce	  a	  secretory	  phenotype	  through	  increased	  calcium-­‐activated	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Isc.	  However,	  the	  underlying	  mechanism	  driving	  this	  increase	  did	  not	  correlate	  directly	  with	  up-­‐regulated	  levels	  of	  KCNN4,	  as	  seen	  at	  an	  MOI	  of	  0.6	  and	  treatment	  with	  conditioned	  media.	  Although	  the	  investigation	  into	  the	  mechanism	  driving	  this	  increase	  is	  beyond	  the	  scope	  of	  this	  study,	  it	  is	  still	  possible	  that	  IL-­‐8	  up-­‐regulates	  a	  potassium	  channel	  other	  than	  KCNN4	  or	  KCNQ1	  in	  order	  to	  drive	  this	  response.	  Therefore,	  our	  hypothesis	  that	  IL-­‐8	  exposure	  would	  increase	  KCNN4	  and	  KCNQ1	  ion	  channel	  function	  was	  not	  confirmed;	  however	  other	  potassium	  channels	  may	  be	  involved.	  Together,	  these	  studies	  have	  revealed	  that	  the	  development	  of	  a	  secretory	  phenotype	  in	  influenza-­‐infected	  airway	  epithelium	  is	  a	  result	  of	  the	  pro-­‐inflammatory	  cytokine	  mixture	  acting	  in	  a	  paracrine	  manner	  on	  non-­‐infected	  cells.	  These	  cytokines	  are	  capable	  of	  up-­‐regulating	  KCNN4	  and	  KCNQ1,	  which	  then	  increase	  the	  driving	  force	  for	  chloride	  secretion.	  	  	   These	  potassium	  channels	  have	  not	  been	  considered	  as	  potential	  targets	  for	  the	  treatment	  of	  influenza-­‐induced	  ARDS	  to	  date,	  but	  the	  results	  presented	  here	  indicate	  that	  this	  may	  be	  a	  viable	  option.	  KCNN4	  already	  has	  a	  clinically	  available	  drug,	  ICA-­‐17043,	  which	  has	  been	  used	  to	  successfully	  treat	  individuals	  with	  sickle	  cell	  anemia[139,140,148].	  Given	  that	  the	  target	  is	  the	  same,	  this	  compound	  may	  prove	  to	  have	  dual	  purpose.	  Additionally,	  this	  research	  may	  have	  implications	  for	  other	  respiratory	  viruses	  as	  many	  complications	  associated	  with	  respiratory	  pathogens	  involve	  formation	  of	  pulmonary	  edema[155,156].	  Respiratory	  syncytial	  virus	  (RSV)	  in	  particular	  has	  been	  shown	  to	  modulate	  vectorial	  ion	  transport	  in	  airway	  epithelium[155].	  If	  the	  mechanisms	  are	  similar,	  the	  therapeutic	  benefits	  of	  potassium	  channel	  inhibitors	  may	  extend	  to	  treat	  multiple	  respiratory	  pathogens.	  	  
	   88	  
	   Overall,	  we	  conclude	  that	  the	  pro-­‐inflammatory	  cytokines	  secreted	  by	  infected	  epithelial	  cells	  are	  capable	  of	  inducing	  a	  secretory	  response	  independently	  of	  the	  virus.	  The	  concerted	  up-­‐regulation	  of	  KCNN4	  and	  KCNQ1	  after	  CM	  treatment	  indicates	  that	  both	  of	  these	  channels	  are	  required	  to	  increase	  apical	  chloride	  secretion.	  IL-­‐8	  treatment	  resulted	  in	  a	  similar	  increase	  in	  secretory	  phenotype;	  however,	  the	  underlying	  mechanism	  remains	  to	  be	  uncovered,	  as	  it	  is	  not	  a	  result	  of	  increased	  KCNN4	  or	  KCNQ1.	  This	  study	  reveals	  the	  impact	  cytokine	  expression	  levels	  have	  on	  airway	  epithelial	  cell	  secretion,	  and	  strongly	  suggest	  that	  the	  host	  immune	  response	  drives	  significant	  components	  of	  influenza	  virus	  pathogenesis.	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